Conus venom peptide pharmacology

Pharmacological Reviews

Volumn 64, Issue 2, 2012, Pages 259-298

  Lewis, Richard J ^a   Dutertre, Sébastien ^a   Vetter, Irina ^a   Christie, Macdonald J ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALANYLCYSTEINYLSERYLLYSLLYSLTRYPTOPHYLGLUTAMYLTYROSYLCYSTEINYLISOLEUCYLVALYLPROLYLISOLEUCYLISOLEUCYLGLYCYLPHENYLALANYLISOLEUCYLTYROSYLCYSTEINYLCYSTEINYLPROLYLGLYCLLEUCYLISOLEUCYLCYSTEINYLGLYCYLPROLYLPHENYLALANYLLVALYLCYSTEINYLVALINE; ASPARAGINYLCYSTEINYLCYSTEINYLASPARAGINYLGLYCYLGLCYLCYSTEINYLSERYLSERYLLYSYLTRYPTOPHYLCYSTEINYLASPARTYLHISTIDYLALANYLARGINYLCYSTEINYLCYSTEINE; ASPARTYLASPARTYLCYSTEINYLISOLEUCYLLYSYLTYROSYLGLYCYLPHENYLALANYLCYSTEINYLSERYLLEUCYLPROLYLISOLEUCYLLYSYLASPARAGINYLGLYCYLALANYLCYTEINYLCYSTEINYLSERYLGLYCYLALANYLCYTEINYLVALYLGLYCYLVALYLCYSTEINYLALANYLASPARTYLLEUCINE; CYSTEINYLARGINYLISOLEUCYLASPARAGINYLGLUTAMINYLLYSYLCYSTEINYLPHENYLALANYLGLUTAMINYLHISTIDYLLEUCYLASPARTYLASPARTYLCYSTEINYLCYSTEINYLSERYLARGINYLLYSYLCYSTEINYLASPARAGINYLASPARAGINYLARGINYLPHENYLALANYLASPARAGINYLLYSYLCYSTEINYLVALINE; CYSTEINYLLYSYLGLYCYLLYSYLGLYCYLALANYLLYSYLCYSTEINYLSERYLARGINYLLEUCYLMETHIONYLTYROSYLASPARTYLCYSTEINYLTHREONYLGLYCYLSERYLGLYCYLSERYLCYSTEINYLARGINYLSERLYGLYCYLLYSYLCYSTEINE; G PROTEIN COUPLED RECEPTOR; GLYCYLCYSTEINYLTHREONYLARGINYLTHREONYLCYSTEINYLGLYCYLGLYCYLLYSYLCYSTEINYLTHREONYLGLYCYLTHREONYLCYSTEINYLTHREONYLCYSTEINYLTHREONYLASPARAGINYLSERYLSERYLLYSYLCYSTEINYLGLYCYLARGINYLTYROSYLASPARAGINYLVALYLALANYLPROLYLSERYLGLYCYLGLCYLCYSTEINYLGLYCYSTEINE; GLYCYLVALYLLCYSTEINYLCYSTEINYLGLYCYLTYROSYLLYSYSLCYSTEINYLHISTIDYLCYSTEINE; ION CHANNEL; NEUROTRANSMITTER; PEPTIDE DERIVATIVE; PHENYLALALNYLASPARAGINYLTRYTOPHYLARGINYLCYSTEINYLCYSTEINYLLEUCYLISOLEUCYLPROLYLALANYLCYSTEINYLARGINYLARGINYLASPARAGINYLHISTIDYLLYSYLLYSYLCYSTEINE; UNCLASSIFIED DRUG; VOLTAGE GATED ION CHANNEL;

BINDING AFFINITY; CRYSTAL STRUCTURE; DRUG EFFICACY; DRUG STRUCTURE; GENE MUTATION; HIGH THROUGHPUT SCREENING; HUMAN; MOLECULAR INTERACTION; NEUROLOGIC DISEASE; NEUROTRANSMISSION; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; PROTEOMICS; REVIEW; SNAIL; STRUCTURE ACTIVITY RELATION; TRANSCRIPTOMICS;

ANIMALS; CONOTOXINS; CONUS SNAIL; DRUG DISCOVERY; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; PEPTIDES; PROTEOMICS; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSCRIPTOME;

EID: 84858178207     PISSN: 00316997     EISSN: 15210081     Source Type: Journal    
DOI: 10.1124/pr.111.005322     Document Type: Review

References (416)

1. Abbott JR and Litzinger MJ (1994) Different ω-conotoxins mark the development of Swiss Webster mouse cortex suggesting N-type voltage sensitive calcium channel subtypes. Int J Dev Neurosci 12:43-47.
2. Abe T and Saisu H (1987) Identification of the receptor for ω-conotoxin in brain. Probable components of the calcium channel. J Biol Chem 262:9877-9882.
3. Adams DJ, Alewood PF, Craik DJ, Drinkwater RD, and Lewis RJ (1999) Conotoxins and their potential pharmaceutical applications. Drug Dev Res 46:219-234.
4. Aguilar MB, López-Vera E, Heimer de la Cotera EP, Falcón A, Olivera BM, and Maillo M (2007) I-conotoxins in vermivorous species of the West Atlantic: peptide sr11a from Conus spurius. Peptides 28:18-23.
5. Aguilar MB, Pérez-Reyes LI, López Z, de la Cotera EP, Falcón A, Ayala C, Galván M, Salvador C, and Escobar LI (2010) Peptide sr11a from Conus spurius is a novel peptide blocker for Kv1 potassium channels. Peptides 31:1287-1291.
6. Ahn HS, Black JA, Zhao P, Tyrrell L, Waxman SG, and Dib-Hajj SD (2011) Nav1.7 is the predominant sodium channel in rodent olfactory sensory neurons. Mol Pain 7:32.
7. Akopian AN, Souslova V, England S, Okuse K, Ogata N, Ure J, Smith A, Kerr BJ, McMahon SB, Boyce S, et al. (1999) The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways. Nat Neurosci 2:541-548.
8. + channel antagonist. Biochemistry 43:8625-8635.
9. Allen JW, Hofer K, McCumber D, Wagstaff JD, Layer RT, McCabe RT, and Yaksh TL (2007) An assessment of the antinociceptive efficacy of intrathecal and epidural contulakin-G in rats and dogs. Anesth Analg 104:1505-1513.
10. Altier C, Dale CS, Kisilevsky AE, Chapman K, Castiglioni AJ, Matthews EA, Evans RM, Dickenson AH, Lipscombe D, Vergnolle N, et al. (2007) Differential role of N-type calcium channel splice isoforms in pain. J Neurosci 27:6363-6373.
11. Amaya F, Wang H, Costigan M, Allchorne AJ, Hatcher JP, Egerton J, Stean T, Morisset V, Grose D, Gunthorpe MJ, et al. (2006) The voltage-gated sodium channel Nav1.9 is an effector of peripheral inflammatory pain hypersensitivity. J Neurosci 26:12852-12860.
12. Andersson A, Baell JB, Duggan PJ, Graham JE, Lewis RJ, Lumsden NG, Tranberg CE, Tuck KL, and Yang A (2009) ω-Conotoxin GVIA mimetics based on an anthranilamide core: effect of variation in ammonium side chain lengths and incorporation of fluorine. Bioorg Med Chem 17:6659-6670.
13. 2+ channels and spinal analgesia couple to alternative splicing. Nat Neurosci 13:1249-1256.
14. Azam L, Dowell C, Watkins M, Stitzel JA, Olivera BM, and McIntosh JM (2005) α-Conotoxin BuIA, a novel peptide from Conus bullatus, distinguishes among neuronal nicotinic acetylcholine receptors. J Biol Chem 280:80-87.
15. Balaji RA, Ohtake A, Sato K, Gopalakrishnakone P, Kini RM, Seow KT, and Bay BH (2000) lambda-conotoxins, a new family of conotoxins with unique disulfide pattern and protein folding. Isolation and characterization from the venom of Conus marmoreus. J Biol Chem 275:39516-39522.
16. Bannon AW, Decker MW, Kim DJ, Campbell JE, and Arneric SP (1998) ABT-594, a novel cholinergic channel modulator, is efficacious in nerve ligation and diabetic neuropathy models of neuropathic pain. Brain Res 801:158-163.
17. + channels but not in skeletal and cardiac muscles. J Biol Chem 279:4680-4685.
18. Bauer CS, Rahman W, Tran-van-Minh A, Lujan R, Dickenson AH, and Dolphin AC (2010) The anti-allodynic α2δ ligand pregabalin inhibits the trafficking of the calcium channel α2δ-1 subunit to presynaptic terminals in vivo. Biochem Soc Trans 38:525-528.
19. Bayrhuber M, Vijayan V, Ferber M, Graf R, Korukottu J, Imperial J, Garrett JE, Olivera BM, Terlau H, Zweckstetter M, et al. (2005) Conkunitzin-S1 is the first member of a new Kunitz-type neurotoxin family. Structural and functional characterization. J Biol Chem 280:23766-23770.
20. Becker S, Prusak-Sochaczewski E, Zamponi G, Beck-Sickinger AG, Gordon RD, and French RJ (1992) Action of derivatives of μ-conotoxin GIIIA on sodium channels. Single amino acid substitutions in the toxin separately affect association and dissociation rates. Biochemistry 31:8229-8238.
21. Bell TJ, Thaler C, Castiglioni AJ, Helton TD, and Lipscombe D (2004) Cell-specific alternative splicing increases calcium channel current density in the pain pathway. Neuron 41:127-138.
22. Berecki G, Motin L, Haythornthwaite A, Vink S, Bansal P, Drinkwater R, Wang CI, Moretta M, Lewis RJ, Alewood PF, et al. (2010) Analgesic ω-conotoxins CVIE and CVIF selectively and voltage-dependently block recombinant and native N-type calcium channels. Mol Pharmacol 77:139-148.
23. Birnbaumer M (2000) Vasopressin receptors. Trends Endocrinol Metab 11:406-410.
24. Black JA, Cummins TR, Plumpton C, Chen YH, Hormuzdiar W, Clare JJ, and Waxman SG (1999) Upregulation of a silent sodium channel after peripheral, but not central, nerve injury in DRG neurons. J Neurophysiol 82:2776-2785.
25. Black JA, Nikolajsen L, Kroner K, Jensen TS, and Waxman SG (2008) Multiple sodium channel isoforms and mitogen-activated protein kinases are present in painful human neuromas. Ann Neurol 64:644-653.
26. Bourinet E, Alloui A, Monteil A, Barrère C, Couette B, Poirot O, Pages A, McRory J, Snutch TP, Eschalier A, et al. (2005) Silencing of the Cav3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception. EMBO J 24:315-324.
27. Bourinet E, Soong TW, Sutton K, Slaymaker S, Mathews E, Monteil A, Zamponi GW, Nargeot J, and Snutch TP (1999) Splicing of α1A subunit gene generates phenotypic variants of P- and Q-type calcium channels. Nat Neurosci 2:407-415.
28. Bosmans F, Puopolo M, Martin-Eauclaire MF, Bean BP, and Swartz KJ (2011) Functional properties and toxin pharmacology of a dorsal root ganglion sodium channel viewed through its voltage sensors. J Gen Physiol 138:59-72.
29. Bowersox SS, Gadbois T, Singh T, Pettus M, Wang YX, and Luther RR (1996) Selective N-type neuronal voltage-sensitive calcium channel blocker, SNX-111, produces spinal antinociception in rat models of acute, persistent and neuropathic pain. J Pharmacol Exp Ther 279:1243-1249.
30. Boyce S, Wyatt A, Webb JK, O'Donnell R, Mason G, Rigby M, Sirinathsinghji D, Hill RG, and Rupniak NM (1999) Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal horn. Neuropharmacology 38:611-623.
31. Bregman H, Berry L, Buchanan JL, Chen A, Du B, Feric E, Hierl M, Huang L, Immke D, Janosky B, et al. (2011) Identification of a potent, state-dependent inhibitor of Nav1.7 with oral efficacy in the formalin model of persistent pain. J Med Chem 54:4427-4445.
32. Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, et al. (2009) χ-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain. J Med Chem 52:6991-7002.
33. Buczek O, Wei D, Babon JJ, Yang X, Fiedler B, Chen P, Yoshikami D, Olivera BM, Bulaj G, and Norton RS (2007) Structure and sodium channel activity of an excitatory I1-superfamily conotoxin. Biochemistry 46:9929-9940.
34. Bulaj G, DeLaCruz R, Azimi-Zonooz A, West P, Watkins M, Yoshikami D, and Olivera BM (2001) α-Conotoxin structure/function through a cladistic analysis. Biochemistry 40:13201-13208.
35. Bulaj G, West PJ, Garrett JE, Watkins M, Marsh M, Zhang MM, Norton RS, Smith BJ, Yoshikami D, and Olivera BM (2005) Novel conotoxins from Conus striatus and Conus kinoshitai selectively block TTX-resistant sodium channels. Biochemistry 44:7259-7265.
36. Bulaj G, Zhang MM, Green BR, Fiedler B, Layer RT, Wei S, Nielsen JS, Low SJ, Klein BD, Wagstaff JD, et al. (2006) Synthetic μO-conotoxin MrVIB blocks TTXresistant sodium channel Nav1.8 and has a long-lasting analgesic activity. Biochemistry 45:7404-7414.
37. Bylund DB, Eikenberg DC, Hieble JP, Langer SZ, Lefkowitz RJ, Minneman KP, Molinoff PB, Ruffolo RR Jr, and Trendelenburg U (1994) International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol Rev 46:121-136.
38. Callaghan B and Adams DJ (2010) Analgesic α-conotoxins Vc1.1 and RgIA inhibit N-type calcium channels in sensory neurons of α9 nicotinic receptor knockout mice. Channels (Austin) 4:51-54.
39. Callaghan B, Haythornthwaite A, Berecki G, Clark RJ, Craik DJ, and Adams DJ (2008) Analgesic α-conotoxins Vc1.1 and Rg1A inhibit N-type calcium channels in rat sensory neurons via GABAB receptor activation. J Neurosci 28:10943-10951.
40. Cartier GE, Yoshikami D, Gray WR, Luo S, Olivera BM, and McIntosh JM (1996) A new α-conotoxin which targets α3β2 nicotinic acetylcholine receptors. J Biol Chem 271:7522-7528.
41. Catterall WA (2010) Signaling complexes of voltage-gated sodium and calcium channels. Neurosci Lett 486:107-116.
42. Catterall WA, Cestèle S, Yarov-Yarovoy V, Yu FH, Konoki K, and Scheuer T (2007) Voltage-gated ion channels and gating modifier toxins. Toxicon 49:124-141.
43. Catterall WA, Goldin AL, and Waxman SG (2005a) International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol Rev 57:397-409.
44. Catterall WA, Perez-Reyes E, Snutch TP, and Striessnig J (2005b) International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels. Pharmacol Rev 57:411-425.
45. Celie PH, Kasheverov IE, Mordvintsev DY, Hogg RC, van Nierop P, van Elk R, van Rossum-Fikkert SE, Zhmak MN, Bertrand D, Tsetlin V, et al. (2005) Crystal structure of nicotinic acetylcholine receptor homolog AChBP in complex with an α-conotoxin PnIA variant. Nat Struct Mol Biol 12:582-588.
46. Chahine M, Chen LQ, Fotouhi N, Walsky R, Fry D, Santarelli V, Horn R, and Kallen RG (1995) Characterizing the μ-conotoxin binding site on voltage-sensitive sodium channels with toxin analogs and channel mutations. Receptors Channels 3:161-174.
47. Chambers JC, Zhao J, Terracciano CM, Bezzina CR, Zhang W, Kaba R, Navaratnarajah M, Lotlikar A, Sehmi JS, Kooner MK, et al. (2010) Genetic variation in SCN10A influences cardiac conduction. Nat Genet 42:149-152.
48. Chan AW, Owens S, Tung C, and Stanley EF (2007) Resistance of presynaptic Cav2.2 channels to voltage-dependent inactivation: dynamic palmitoylation and voltage sensitivity. Cell Calcium 42:419-425.
49. + channel localized by mutant cycle analysis. Biochemistry 37:4407-4419.
50. Chen P, Dendorfer A, Finol-Urdaneta RK, Terlau H, and Olivera BM (2010) Biochemical characterization of κM-RIIIJ, a Kv1.2 channel blocker: evaluation of cardioprotective effects of κM-conotoxins. J Biol Chem 285:14882-14889.
51. Chen PE and Wyllie DJ (2006) Pharmacological insights obtained from structurefunction studies of ionotropic glutamate receptors. Br J Pharmacol 147:839-853.
52. Chen Z, Rogge G, Hague C, Alewood D, Colless B, Lewis RJ, and Minneman KP (2004) Subtype-selective noncompetitive or competitive inhibition of human α1-adrenergic receptors by ρ-TIA. J Biol Chem 279:35326-35333.
53. Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SG, Thian FS, Kobilka TS, Choi HJ, Kuhn P, Weis WI, Kobilka BK, et al. (2007) High-resolution crystal structure of an engineered human 2-adrenergic G protein-coupled receptor. Science 318:1258-1265.
54. Chien EY, Liu W, Zhao Q, Katritch V, Han GW, Hanson MA, Shi L, Newman AH, Javitch JA, Cherezov V, et al. (2010) Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist. Science 330:1091-1095.
55. Choe W, Messinger RB, Leach E, Eckle VS, Obradovic A, Salajegheh R, Jevtovic-Todorovic V, and Todorovic SM (2011) TTA-P2 is a potent and selective blocker of T-type calcium channels in rat sensory neurons and a novel antinociceptive agent. Mol Pharmacol 80:900-910.
56. Choi JY, Seo HN, Lee MJ, Park SJ, Park SJ, Jeon JY, Kang JH, Pae AN, Rhim H, and Lee JY (2007) Synthesis and biological evaluation of novel T-type calcium channel blockers. Bioorg Med Chem Lett 17:471-475.
57. Chowdhury S, Chafeev M, Liu S, Sun J, Raina V, Chui R, Young W, Kwan R, Fu J, and Cadieux JA (2011) Discovery of XEN907, a spirooxindole blocker of Nav1.7 for the treatment of pain. Bioorg Med Chem Lett 21:3676-3681.
58. Chung D, Gaur S, Bell JR, Ramachandran J, and Nadasdi L (1995) Determination of disulfide bridge pattern in ω-conopeptides. Int J Pept Protein Res 46:320-325.
59. Ciabarra AM, Sullivan JM, Gahn LG, Pecht G, Heinemann S, and Sevarino KA (1995) Cloning and characterization of chi-1: a developmentally regulated member of a novel class of the ionotropic glutamate receptor family. J Neurosci 15:6498-6508.
60. Clark RJ, Fischer H, Nevin ST, Adams DJ, and Craik DJ (2006) The synthesis, structural characterization, and receptor specificity of the α-conotoxin Vc1.1. J Biol Chem 281:23254-23263.
61. Clark RJ, Jensen J, Nevin ST, Callaghan BP, Adams DJ, and Craik DJ (2010) The engineering of an orally active conotoxin for the treatment of neuropathic pain. Angew Chem Int Ed Engl 49:6545-6548.
62. Conn PJ, Christopoulos A, and Lindsley CW (2009) Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders. Nat Rev Drug Discov 8:41-54.
63. Copeland RA, Pompliano DL, and Meek TD (2006) Drug-target residence time and its implications for lead optimization. Nat Rev Drug Discov 5:730-739.
64. Cox JJ, Reimann F, Nicholas AK, Thornton G, Roberts E, Springell K, Karbani G, Jafri H, Mannan J, Raashid Y, et al. (2006) An SCN9A channelopathy causes congenital inability to experience pain. Nature 444:894-898.
65. Craig AG, Norberg T, Griffin D, Hoeger C, Akhtar M, Schmidt K, Low W, Dykert J, Richelson E, Navarro V, et al. (1999) Contulakin-G, an O-glycosylated invertebrate neurotensin. J Biol Chem 274:13752-13759.
66. Craig AG, Park M, Fischer WH, Kang J, Compain P, and Piller F (2001) Enzymatic glycosylation of contulakin-G, a glycopeptide isolated from Conus venom, with a mammalian ppGalNAc-transferase. Toxicon 39:809-815.
67. Craig AG, Zafaralla G, Cruz LJ, Santos AD, Hillyard DR, Dykert J, Rivier JE, Gray WR, Imperial J, DelaCruz RG, et al. (1998) An O-glycosylated neuroexcitatory Conus peptide. Biochemistry 37:16019-16025.
68. Cruz LJ, de Santos V, Zafaralla GC, Ramilo CA, Zeikus R, Gray WR, and Olivera BM (1987) Invertebrate vasopressin/oxytocin homologs. Characterization of peptides from Conus geographus and Conus straitus venoms. J Biol Chem 262:15821-15824.
69. Cruz LJ, Gray WR, Olivera BM, Zeikus RD, Kerr L, Yoshikami D, and Moczydlowski E (1985) Conus geographus toxins that discriminate between neuronal and muscle sodium channels. J Biol Chem 260:9280-9288.
70. Cummins TR, Howe JR, and Waxman SG (1998) Slow closed-state inactivation: a novel mechanism underlying ramp currents in cells expressing the hNE/PN1 sodium channel. J Neurosci 18:9607-9619.
71. Cummins TR and Rush AM (2007) Voltage-gated sodium channel blockers for the treatment of neuropathic pain. Expert Rev Neurother 7:1597-1612.
72. Cusdin FS, Nietlispach D, Maman J, Dale TJ, Powell AJ, Clare JJ, and Jackson AP (2010) The sodium channel {beta}3-subunit induces multiphasic gating in Nav1.3 and affects fast inactivation via distinct intracellular regions. J Biol Chem 285: 33404-33412.
73. Daly NL, Ekberg JA, Thomas L, Adams DJ, Lewis RJ, and Craik DJ (2004) Structures of μO-conotoxins from Conus marmoreus. Inhibitors of tetrodotoxin (TTX)-sensitive and TTX-resistant sodium channels in mammalian sensory neurons. J Biol Chem 279:25774-25782.
74. Davis J, Jones A, and Lewis RJ (2009) Remarkable inter- and intra-species complexity of conotoxins revealed by LC/MS. Peptides 30:1222-1227.
75. de Araujo AD, Callaghan B, Nevin ST, Daly NL, Craik DJ, Moretta M, Hopping G, Christie MJ, Adams DJ, and Alewood PF (2011) Total synthesis of the analgesic conotoxin MrVIB through selenocysteine-assisted folding. Angew Chem Int Ed Engl 50:6527-6529.
76. Dib-Hajj SD, Black JA, and Waxman SG (2009) Voltage-gated sodium channels: therapeutic targets for pain. Pain Med 10:1260-1269.
77. Dib-Hajj SD, Cummins TR, Black JA, and Waxman SG (2010) Sodium channels in normal and pathological pain. Annu Rev Neurosci 33:325-347.
78. Dingledine R, Borges K, Bowie D, and Traynelis SF (1999) The glutamate receptor ion channels. Pharmacol Rev 51:7-61.
79. Dogrul A, Gardell LR, Ossipov MH, Tulunay FC, Lai J, and Porreca F (2003) Reversal of experimental neuropathic pain by T-type calcium channel blockers. Pain 105:159-168.
80. Dowell C, Olivera BM, Garrett JE, Staheli ST, Watkins M, Kuryatov A, Yoshikami D, Lindstrom JM, and McIntosh JM (2003) α-Conotoxin PIA is selective for α6subunit-containing nicotinic acetylcholine receptors. J Neurosci 23:8445-8452.
81. Drew LJ, Rugiero F, Cesare P, Gale JE, Abrahamsen B, Bowden S, Heinzmann S, Robinson M, Brust A, Colless B, et al. (2007) High-threshold mechanosensitive ion channels blocked by a novel conopeptide mediate pressure-evoked pain. PLoS One 2:e515.
82. + channel mutant: possible localization of a binding site at the outer vestibule. Biophys J 69:1657-1665.
83. Dutertre S, Croker D, Daly NL, Andersson A, Muttenthaler M, Lumsden NG, Craik DJ, Alewood PF, Guillon G, and Lewis RJ (2008) Conopressin-T from Conus tulipa reveals an antagonist switch in vasopressin-like peptides. J Biol Chem 283:7100-7108.
84. Dutertre S, Nicke A, and Lewis RJ (2005) 2 subunit contribution to 4/7 α-conotoxin binding to the nicotinic acetylcholine receptor. J Biol Chem 280:30460-30468.
85. Dutertre S, Nicke A, Tyndall JD, and Lewis RJ (2004) Determination of α-conotoxin binding modes on neuronal nicotinic acetylcholine receptors. J Mol Recognit 17: 339-347.
86. Dutertre S, Ulens C, Büttner R, Fish A, van Elk R, Kendel Y, Hopping G, Alewood PF, Schroeder C, Nicke A, et al. (2007) AChBP-targeted α-conotoxin correlates distinct binding orientations with nAChR subtype selectivity. EMBO J 26:3858-3867.
87. Dworkin RH, O'Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, Kalso EA, Loeser JD, Miaskowski C, Nurmikko TJ, et al. (2007) Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 132:237-251.
88. Ekberg J, Jayamanne A, Vaughan CW, Aslan S, Thomas L, Mould J, Drinkwater R, Baker MD, Abrahamsen B, Wood JN, et al. (2006) μO-conotoxin MrVIB selectively blocks Nav1.8 sensory neuron specific sodium channels and chronic pain behavior without motor deficits. Proc Natl Acad Sci USA 103:17030-17035.
89. Ellinor PT, Zhang JF, Horne WA, and Tsien RW (1994) Structural determinants of the blockade of N-type calcium channels by a peptide neurotoxin. Nature 372:272-275.
90. Ellison M, Feng ZP, Park AJ, Zhang X, Olivera BM, McIntosh JM, and Norton RS (2008) α-RgIA, a novel conotoxin that blocks the α9α10 nAChR: structure and identification of key receptor-binding residues. J Mol Biol 377:1216-1227.
91. Ellison M, Gao F, Wang HL, Sine SM, McIntosh JM, and Olivera BM (2004) α-Conotoxins ImI and ImII target distinct regions of the human α7 nicotinic acetylcholine receptor and distinguish human nicotinic receptor subtypes. Biochemistry 43:16019-16026.
92. Ellison M, Haberlandt C, Gomez-Casati ME, Watkins M, Elgoyhen AB, McIntosh JM, and Olivera BM (2006) α-RgIA: a novel conotoxin that specifically and potently blocks the α9α10 nAChR. Biochemistry 45:1511-1517.
93. England LJ, Imperial J, Jacobsen R, Craig AG, Gulyas J, Akhtar M, Rivier J, Julius D, and Olivera BM (1998) Inactivation of a serotonin-gated ion channel by a polypeptide toxin from marine snails. Science 281:575-578.
94. England S and de Groot MJ (2009) Subtype-selective targeting of voltage-gated sodium channels. Br J Pharmacol 158:1413-1425.
95. Everhart D, Reiller E, Mirzoian A, McIntosh JM, Malhotra A, and Luetje CW (2003) Identification of residues that confer α-conotoxin-PnIA sensitivity on the α3 subunit of neuronal nicotinic acetylcholine receptors. J Pharmacol Exp Ther 306:664-670.
96. Fainzilber M, Hasson A, Oren R, Burlingame AL, Gordon D, Spira ME, and Zlotkin E (1994a) New mollusc-specific α-conotoxins block Aplysia neuronal acetylcholine receptors. Biochemistry 33:9523-9529.
97. Fainzilber M, Kofman O, Zlotkin E, and Gordon D (1994b) A new neurotoxin receptor site on sodium channels is identified by a conotoxin that affects sodium channel inactivation in molluscs and acts as an antagonist in rat brain. J Biol Chem 269:2574-2580.
98. Fainzilber M, Lodder JC, Kits KS, Kofman O, Vinnitsky I, Van Rietschoten J, Zlotkin E, and Gordon D (1995a) A new conotoxin affecting sodium current inactivation interacts with the δ-conotoxin receptor site. J Biol Chem 270:1123-1129.
99. Fainzilber M, Lodder JC, van der Schors RC, Li KW, Yu Z, Burlingame AL, Geraerts WP, and Kits KS (1996) A novel hydrophobic ω-conotoxin blocks molluscan dihydropyridine-sensitive calcium channels. Biochemistry 35:8748-8752.
100. Fainzilber M, Nakamura T, Gaathon A, Lodder JC, Kits KS, Burlingame AL, and Zlotkin E (1995b) A new cysteine framework in sodium channel blocking conotoxins. Biochemistry 34:8649-8656.
101. Fainzilber M, van der Schors R, Lodder JC, Li KW, Geraerts WP, and Kits KS (1995c) New sodium channel-blocking conotoxins also affect calcium currents in Lymnaea neurons. Biochemistry 34:5364-5371.
102. Fan CX, Chen XK, Zhang C, Wang LX, Duan KL, He LL, Cao Y, Liu SY, Zhong MN, Ulens C, et al. (2003) A novel conotoxin from Conus betulinus, κ-BtX, unique in cysteine pattern and in function as a specific BK channel modulator. J Biol Chem 278:12624-12633.
103. Fang X, Djouhri L, McMullan S, Berry C, Waxman SG, Okuse K, and Lawson SN (2006) Intense isolectin-B4 binding in rat dorsal root ganglion neurons distinguishes C-fiber nociceptors with broad action potentials and high Nav1.9 expression. J Neurosci 26:7281-7292.
104. Favreau P, Gilles N, Lamthanh H, Bournaud R, Shimahara T, Bouet F, Laboute P, Letourneux Y, Ménez A, Molgó J, et al. (2001) A new ω-conotoxin that targets N-type voltage-sensitive calcium channels with unusual specificity. Biochemistry 40:14567-14575.
105. Favreau P, Krimm I, Le Gall F, Bobenrieth MJ, Lamthanh H, Bouet F, Servent D, Molgo J, Ménez A, Letourneux Y, et al. (1999) Biochemical characterization and nuclear magnetic resonance structure of novel α-conotoxins isolated from the venom of Conus consors. Biochemistry 38:6317-6326.
106. Felts PA, Yokoyama S, Dib-Hajj S, Black JA, and Waxman SG (1997) Sodium channel α-subunit mRNAs I, II, III, NaG, Na6 and hNE (PN1): different expression patterns in developing rat nervous system. Brain Res Mol Brain Res 45: 71-82.
107. Feng ZP, Hamid J, Doering C, Bosey GM, Snutch TP, and Zamponi GW (2001) Residue Gly1326 of the N-type calcium channel α1B subunit controls reversibility of ω-conotoxin GVIA and MVIIA block. J Biol Chem 276:15728-15735.
108. Ferber M, Al-Sabi A, Stocker M, Olivera BM, and Terlau H (2004) Identification of a mammalian target of κM-conotoxin RIIIK. Toxicon 43:915-921.
109. + channels. J Biol Chem 278:2177-2183.
110. Fertleman CR, Baker MD, Parker KA, Moffatt S, Elmslie FV, Abrahamsen B, Ostman J, Klugbauer N, Wood JN, Gardiner RM, et al. (2006) SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes. Neuron 52:767-774.
111. Fiedler B, Zhang MM, Buczek O, Azam L, Bulaj G, Norton RS, Olivera BM, and Yoshikami D (2008) Specificity, affinity and efficacy of ι-conotoxin RXIA, an agonist of voltage-gated sodium channels Nav1.2, 1.6 and 1.7. Biochem Pharmacol 75:2334-2344.
112. Flinn JP, Pallaghy PK, Lew MJ, Murphy R, Angus JA, and Norton RS (1999) Roles of key functional groups in ω-conotoxin GVIA synthesis, structure and functional assay of selected peptide analogues. Eur J Biochem 262:447-455.
113. Fossat P, Dobremez E, Bouali-Benazzouz R, Favereaux A, Bertrand SS, Kilk K, Léger C, Cazalets JR, Langel U, Landry M, et al. (2010) Knockdown of L calcium channel subtypes: differential effects in neuropathic pain. J Neurosci 30:1073-1085.
114. Fozzard HA and Lipkind GM (2010) The tetrodotoxin binding site is within the outer vestibule of the sodium channel. Mar Drugs 8:219-234.
115. Franco A, Pisarewicz K, Moller C, Mora D, Fields GB, and Marì F (2006) Hyperhydroxylation: a new strategy for neuronal targeting by venomous marine molluscs. Prog Mol Subcell Biol 43:83-103.
116. Fry BG, Roelants K, Champagne DE, Scheib H, Tyndall JD, King GF, Nevalainen TJ, Norman JA, Lewis RJ, Norton RS, et al. (2009) The toxicogenomic multiverse: convergent recruitment of proteins into animal venoms. Annu Rev Genomics Hum Genet 10:483-511.
117. Fukuoka T, Kobayashi K, Yamanaka H, Obata K, Dai Y, and Noguchi K (2008) Comparative study of the distribution of the α-subunits of voltage-gated sodium channels in normal and axotomized rat dorsal root ganglion neurons. J Comp Neurol 510:188-206.
118. Furukawa H and Gouaux E (2003) Mechanisms of activation, inhibition and specificity: crystal structures of the NMDA receptor NR1 ligand-binding core. EMBO J 22:2873-2885.
119. Furukawa H, Singh SK, Mancusso R, and Gouaux E (2005) Subunit arrangement and function in NMDA receptors. Nature 438:185-192.
120. Fuxe K, Von Euler G, Agnati LF, Merlo Pich E, O'Connor WT, Tanganelli S, Li XM, Tinner B, Cintra A, and Carani C (1992) Intramembrane interactions between neurotensin receptors and dopamine D2 receptors as a major mechanism for the neuroleptic-like action of neurotensin. Ann NY Acad Sci 668:186-204.
121. Gandía L, Lara B, Imperial JS, Villarroya M, Albillos A, Maroto R, García AG, and Olivera BM (1997) Analogies and differences between ω-conotoxins MVIIC and MVIID: binding sites and functions in bovine chromaffin cells. Pflugers Arch 435:55-64.
122. García E, Scanlon M, and Naranjo D (1999) A marine snail neurotoxin shares with scorpion toxins a convergent mechanism of blockade on the pore of voltage-gated K channels. J Gen Physiol 114:141-157.
123. Gardezi SR, Taylor P, and Stanley EF (2010) Long C terminal splice variant Cav2.2 identified in presynaptic membrane by mass spectrometric analysis. Channels (Austin) 4:58-62.
124. Genzen JR and McGehee DS (2005) Nicotinic modulation of GABAergic synaptic transmission in the spinal cord dorsal horn. Brain Res 1031:229-237.
125. Goddard AW, Ball SG, Martinez J, Robinson MJ, Yang CR, Russell JM, and Shekhar A (2010) Current perspectives of the roles of the central norepinephrine system in anxiety and depression. Depress Anxiety 27:339-350.
126. Gold MS, Weinreich D, Kim CS, Wang R, Treanor J, Porreca F, and Lai J (2003) Redistribution of Nav1.8 in uninjured axons enables neuropathic pain. J Neurosci 23:158-166.
127. Goldberg YP, MacFarlane J, MacDonald ML, Thompson J, Dube MP, Mattice M, Fraser R, Young C, Hossain S, Pape T, et al. (2007) Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations. Clin Genet 71:311-319.
128. Gowd KH, Twede V, Watkins M, Krishnan KS, Teichert RW, Bulaj G, and Olivera BM (2008) Conantokin-P, an unusual conantokin with a long disulfide loop. Toxicon 52:203-213.
129. Graham RM, Perez DM, Hwa J, and Piascik MT (1996) α1-Adrenergic receptor subtypes. Molecular structure, function, and signaling. Circ Res 78:737-749.
130. Gray WR, Luque A, Olivera BM, Barrett J, and Cruz LJ (1981) Peptide toxins from Conus geographus venom. J Biol Chem 256:4734-4740.
131. Grishin AA, Wang CI, Muttenthaler M, Alewood PF, Lewis RJ, and Adams DJ (2010) Alpha-conotoxin AuIB isomers exhibit distinct inhibitory mechanisms and differential sensitivity to stoichiometry of alpha3beta4 nicotinic acetylcholine receptors. J Biol Chem 285:22254-22263.
132. Haack JA, Kinser P, Yoshikami D, and Olivera BM (1993) Biotinylated derivatives of ω-conotoxins GVIA and MVIID: probes for neuronal calcium channels. Neuropharmacology 32:1151-1159.
133. Haack JA, Rivier J, Parks TN, Mena EE, Cruz LJ, and Olivera BM (1990) Conantokin-T. A gamma-carboxyglutamate containing peptide with N-methyl-daspartate antagonist activity. J Biol Chem 265:6025-6029.
134. Hains BC, Klein JP, Saab CY, Craner MJ, Black JA, and Waxman SG (2003) Upregulation of sodium channel Nav1.3 and functional involvement in neuronal hyperexcitability associated with central neuropathic pain after spinal cord injury. J Neurosci 23:8881-8892.
135. Halai R, Clark RJ, Nevin ST, Jensen JE, Adams DJ, and Craik DJ (2009) Scanning mutagenesis of α-conotoxin Vc1.1 reveals residues crucial for activity at the α9α10 nicotinic acetylcholine receptor. J Biol Chem 284:20275-20284.
136. Han C, Rush AM, Dib-Hajj SD, Li S, Xu Z, Wang Y, Tyrrell L, Wang X, Yang Y, and Waxman SG (2006) Sporadic onset of erythermalgia: a gain-of-function mutation in Nav1.7. Ann Neurol 59:553-558.
137. Hansen SB, Sulzenbacher G, Huxford T, Marchot P, Taylor P, and Bourne Y (2005) Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations. EMBO J 24:3635-3646.
138. Härterich S, Koschatzky S, Einsiedel J, and Gmeiner P (2008) Novel insights into GPCR-peptide interactions: mutations in extracellular loop 1, ligand backbone methylations and molecular modeling of neurotensin receptor 1. Bioorg Med Chem 16:9359-9368.
139. Harvey SC, McIntosh JM, Cartier GE, Maddox FN, and Luetje CW (1997) Determinants of specificity for α-conotoxin MII on α3β2 neuronal nicotinic receptors. Mol Pharmacol 51:336-342.
140. Hasson A, Shon KJ, Olivera BM, and Spira ME (1995) Alterations of voltageactivated sodium current by a novel conotoxin from the venom of Conus gloriamaris. J Neurophysiol 73:1295-1301.
141. + channels to nociceptive transmission in rat spinal lamina I neurons. Eur J Neurosci 19:103-111.
142. Heinke B, Gingl E, and Sandkühler J (2011) Multiple targets of μ-opioid receptormediated presynaptic inhibition at primary afferent Aδ- and C-fibers. J Neurosci 31:1313-1322.
143. Henderson LP, Gdovin MJ, Liu C, Gardner PD, and Maue RA (1994) Nerve growth factor increases nicotinic ACh receptor gene expression and current density in wild-type and protein kinase A-deficient PC12 cells. J Neurosci 14:1153-1163.
144. Henriques ST and Craik DJ (2010) Cyclotides as templates in drug design. Drug Discov Today 15:57-64.
145. + channels by G-protein beta gamma subunits. Nature 380:258-262.
146. Hermans E and Maloteaux JM (1998) Mechanisms of regulation of neurotensin receptors. Pharmacol Ther 79:89-104.
147. Hieble JP and Ruffolo RR, Jr. (1996) The use of α-adrenoceptor antagonists in the pharmacological management of benign prostatic hypertrophy: an overview. Pharmacol Res 33:145-160.
148. Hildebrand ME, Smith PL, Bladen C, Eduljee C, Xie JY, Chen L, Fee-Maki M, Doering CJ, Mezeyova J, Zhu Y, et al. (2011) A novel slow-inactivation-specific ion channel modulator attenuates neuropathic pain. Pain 152:833-843.
149. Hill JM, Alewood PF, and Craik DJ (1997) Solution structure of the sodium channel antagonist conotoxin GS: a new molecular caliper for probing sodium channel geometry. Structure 5:571-583.
150. + channels. Neuron 9:69-77.
151. Hogg RC, Miranda LP, Craik DJ, Lewis RJ, Alewood PF, and Adams DJ (1999) Single amino acid substitutions in α-conotoxin PnIA shift selectivity for subtypes of the mammalian neuronal nicotinic acetylcholine receptor. J Biol Chem 274: 36559-36564.
152. Holford M, Zhang MM, Gowd KH, Azam L, Green BR, Watkins M, Ownby JP, Yoshikami D, Bulaj G, and Olivera BM (2009) Pruning nature: Biodiversityderived discovery of novel sodium channel blocking conotoxins from Conus bullatus. Toxicon 53:90-98.
153. Hopkins C, Grilley M, Miller C, Shon KJ, Cruz LJ, Gray WR, Dykert J, Rivier J, Yoshikami D, and Olivera BM (1995) A new family of Conus peptides targeted to the nicotinic acetylcholine receptor. J Biol Chem 270:22361-22367.
154. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, and Humphrey PP (1994) International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol Rev 46:157-203.
155. Huang X, Dong F, and Zhou HX (2005) Electrostatic recognition and induced fit in the κ-PVIIA toxin binding to Shaker potassium channel. J Am Chem Soc 127: 6836-6849.
156. Hui K, Lipkind G, Fozzard HA, and French RJ (2002) Electrostatic and steric contributions to block of the skeletal muscle sodium channel by μ-conotoxin. J Gen Physiol 119:45-54.
157. Hui K, McIntyre D, and French RJ (2003) Conotoxins as sensors of local pH and electrostatic potential in the outer vestibule of the sodium channel. J Gen Physiol 122:63-79.
158. Ikeda H, Heinke B, Ruscheweyh R, and Sandkühler J (2003) Synaptic plasticity in spinal lamina I projection neurons that mediate hyperalgesia. Science 299:1237-1240.
159. Ikeda H, Stark J, Fischer H, Wagner M, Drdla R, Jäger T, and Sandkühler J (2006) Synaptic amplifier of inflammatory pain in the spinal dorsal horn. Science 312: 1659-1662.
160. Ikeda SR (1996) Voltage-dependent modulation of N-type calcium channels by Gprotein βγ subunits. Nature 380:255-258.
161. Imperial JS, Bansal PS, Alewood PF, Daly NL, Craik DJ, Sporning A, Terlau H, López-Vera E, Bandyopadhyay PK, and Olivera BM (2006) A novel conotoxin inhibitor of Kv1.6 channel and nAChR subtypes defines a new superfamily of conotoxins. Biochemistry 45:8331-8340.
162. Jacobsen R, Yoshikami D, Ellison M, Martinez J, Gray WR, Cartier GE, Shon KJ, Groebe DR, Abramson SN, Olivera BM, et al. (1997) Differential targeting of nicotinic acetylcholine receptors by novel αA-conotoxins. J Biol Chem 272:22531-22537.
163. Jagodic MM, Pathirathna S, Joksovic PM, Lee W, Nelson MT, Naik AK, Su P, Jevtovic-Todorovic V, and Todorovic SM (2008) Upregulation of the T-type calcium current in small rat sensory neurons after chronic constrictive injury of the sciatic nerve. J Neurophysiol 99:3151-3156.
164. Jagodic MM, Pathirathna S, Nelson MT, Mancuso S, Joksovic PM, Rosenberg ER, Bayliss DA, Jevtovic-Todorovic V, and Todorovic SM (2007) Cell-specific alterations of T-type calcium current in painful diabetic neuropathy enhance excitability of sensory neurons. J Neurosci 27:3305-3316.
165. Jarvis MF, Honore P, Shieh CC, Chapman M, Joshi S, Zhang XF, Kort M, Carroll W, Marron B, Atkinson R, et al. (2007) A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat. Proc Natl Acad Sci USA 104:8520-8525.
166. Jimenez EC, Donevan S, Walker C, Zhou LM, Nielsen J, Cruz LJ, Armstrong H, White HS, and Olivera BM (2002) Conantokin-L, a new NMDA receptor antagonist: determinants for anticonvulsant potency. Epilepsy Res 51:73-80.
167. Jimenez EC, Olivera BM, and Teichert RW (2007) αC-conotoxin PrXA: a new family of nicotinic acetylcholine receptor antagonists. Biochemistry 46:8717-8724.
168. Jimenez EC, Shetty RP, Lirazan M, Rivier J, Walker C, Abogadie FC, Yoshikami D, Cruz LJ, and Olivera BM (2003) Novel excitatory Conus peptides define a new conotoxin superfamily. J Neurochem 85:610-621.
169. Jin AH, Daly NL, Nevin ST, Wang CI, Dutertre S, Lewis RJ, Adams DJ, Craik DJ, and Alewood PF (2008) Molecular engineering of conotoxins: the importance of loop size to α-conotoxin structure and function. J Med Chem 51:5575-5584.
170. Jobling P, Gibbins IL, Lewis RJ, and Morris JL (2004) Differential expression of calcium channels in sympathetic and parasympathetic preganglionic inputs to neurons in paracervical ganglia of guinea-pigs. Neuroscience 127:455-466.
171. Kaneko S, Cooper CB, Nishioka N, Yamasaki H, Suzuki A, Jarvis SE, Akaike A, Satoh M, and Zamponi GW (2002) Identification and characterization of novel human Cav2.2 (α1B) calcium channel variants lacking the synaptic protein interaction site. J Neurosci 22:82-92.
172. Karnovsky AM, Gotow LF, McKinley DD, Piechan JL, Ruble CL, Mills CJ, Schellin KA, Slightom JL, Fitzgerald LR, Benjamin CW, et al. (2003) A cluster of novel serotonin receptor 3-like genes on human chromosome 3. Gene 319:137-148.
173. Kauferstein S, Huys I, Lamthanh H, Stöcklin R, Sotto F, Menez A, Tytgat J, and Mebs D (2003) A novel conotoxin inhibiting vertebrate voltage-sensitive potassium channels. Toxicon 42:43-52.
174. Kauferstein S, Kendel Y, Nicke A, Coronas FI, Possani LD, Favreau P, Krizaj I, Wunder C, Kauert G, and Mebs D (2009) New conopeptides of the D-superfamily selectively inhibiting neuronal nicotinic acetylcholine receptors. Toxicon 54:295-301.
175. Kauferstein S, Porth C, Kendel Y, Wunder C, Nicke A, Kordis D, Favreau P, Koua D, Stöcklin R, and Mebs D (2011) Venomic study on cone snails (Conus spp.) from South Africa. Toxicon 57:28-34.
176. Kern SE, Allen J, Wagstaff J, Shafer SL, and Yaksh T (2007) The pharmacokinetics of the conopeptide contulakin-G (CGX-1160) after intrathecal administration: an analysis of data from studies in beagles. Anesth Analg 104:1514-1520.
177. Khan I, Osaka H, Stanislaus S, Calvo RM, Deerinck T, Yaksh TL, and Taylor P (2003) Nicotinic acetylcholine receptor distribution in relation to spinal neurotransmission pathways. J Comp Neurol 467:44-59.
178. Kim DS, Yoon CH, Lee SJ, Park SY, Yoo HJ, and Cho HJ (2001) Changes in voltage-gated calcium channel α1 gene expression in rat dorsal root ganglia following peripheral nerve injury. Brain Res Mol Brain Res 96:151-156.
179. Kim JI, Takahashi M, Ogura A, Kohno T, Kudo Y, and Sato K (1994) Hydroxyl group of Tyr13 is essential for the activity of ω-conotoxin GVIA, a peptide toxin for N-type calcium channel. J Biol Chem 269:23876-23878.
180. Kim JI, Takahashi M, Ohtake A, Wakamiya A, and Sato K (1995) Tyr13 is essential for the activity of ω-conotoxin MVIIA and GVIA, specific N-type calcium channel blockers. Biochem Biophys Res Commun 206:449-454.
181. Kis-Toth K, Hajdu P, Bacskai I, Szilagyi O, Papp F, Szanto A, Posta E, Gogolak P, Panyi G, and Rajnavolgyi E (2011) Voltage-gated sodium channel Nav1.7 maintains the membrane potential and regulates the activation and chemokine-induced migration of a monocyte-derived dendritic cell subset. J Immunol 187:1273-1280.
182. Kits KS, Lodder JC, van der Schors RC, Li KW, Geraerts WP, and Fainzilber M (1996) Novel ω-conotoxins block dihydropyridine-insensitive high voltageactivated calcium channels in molluscan neurons. J Neurochem 67:2155-2163.
183. Klein RC, Prorok M, Galdzicki Z, and Castellino FJ (2001) The amino acid residue at sequence position 5 in the conantokin peptides partially governs subunit-selective antagonism of recombinant N-methyl-D-aspartate receptors. J Biol Chem 276: 26860-26867.
184. Klimis H, Adams DJ, Callaghan B, Nevin S, Alewood PF, Vaughan CW, Mozar CA, and Christie MJ (2011) A novel mechanism of inhibition of high-voltage activated calcium channels by α-conotoxins contributes to relief of nerve injury-induced neuropathic pain. Pain 152:259-266.
185. Koch WJ, Rockman HA, Samama P, Hamilton RA, Bond RA, Milano CA, and Lefkowitz RJ (1995) Cardiac function in mice overexpressing the -adrenergic receptor kinase or a ARK inhibitor. Science 268:1350-1353.
186. Kolosov A, Aurini L, Williams ED, Cooke I, and Goodchild CS (2011) Intravenous injection of leconotide, an ω conotoxin: synergistic antihyperalgesic effects with morphine in a rat model of bone cancer pain. Pain Med 12:923-941.
187. Kolosov A, Goodchild CS, and Cooke I (2010) CNSB004 (Leconotide) causes antihyperalgesia without side effects when given intravenously: a comparison with ziconotide in a rat model of diabetic neuropathic pain. Pain Med 11:262-273.
188. Lai J, Gold MS, Kim CS, Bian D, Ossipov MH, Hunter JC, and Porreca F (2002) Inhibition of neuropathic pain by decreased expression of the tetrodotoxinresistant sodium channel, Nav1.8. Pain 95:143-152.
189. Lang PM, Burgstahler R, Haberberger RV, Sippel W, and Grafe P (2005) A Conus peptide blocks nicotinic receptors of unmyelinated axons in human nerves. Neuroreport 16:479-483.
190. Lang PM, Burgstahler R, Sippel W, Irnich D, Schlotter-Weigel B, and Grafe P (2003) Characterization of neuronal nicotinic acetylcholine receptors in the membrane of unmyelinated human C-fiber axons by in vitro studies. J Neurophysiol 90:3295-3303.
191. Langer SZ (1974) Presynaptic regulation of catecholamine release. Biochem Pharmacol 23:1793-1800.
192. Layer RT, Wagstaff JD, and White HS (2004) Conantokins: peptide antagonists of NMDA receptors. Curr Med Chem 11:3073-3084.
193. + channels. Mol Pain 6:97.
194. Leipold E, DeBie H, Zorn S, Borges A, Olivera BM, Terlau H, and Heinemann SH (2007) μO conotoxins inhibit Nav channels by interfering with their voltage sensors in domain-2. Channels (Austin) 1:253-262.
195. Leipold E, Hansel A, Borges A, and Heinemann SH (2006) Subtype specificity of scorpion beta-toxin Tz1 interaction with voltage-gated sodium channels is determined by the pore loop of domain 3. Mol Pharmacol 70:340-347.
196. Leipold E, Hansel A, Olivera BM, Terlau H, and Heinemann SH (2005) Molecular interaction of δ-conotoxins with voltage-gated sodium channels. FEBS Lett 579: 3881-3884.
197. Leipold E, Markgraf R, Miloslavina A, Kijas M, Schirmeyer J, Imhof D, and Heinemann SH (2011) Molecular determinants for the subtype specificity of μ-conotoxin SIIIA targeting neuronal voltage-gated sodium channels. Neuropharmacology 61: 105-111.
198. Leo S, D'Hooge R, and Meert T (2010) Exploring the role of nociceptor-specific sodium channels in pain transmission using Nav1.8 and Nav1.9 knockout mice. Behav Brain Res 208:149-157.
199. Lew MJ, Flinn JP, Pallaghy PK, Murphy R, Whorlow SL, Wright CE, Norton RS, and Angus JA (1997) Structure-function relationships of ω-conotoxin GVIA. Synthesis, structure, calcium channel binding, and functional assay of alanine-substituted analogues. J Biol Chem 272:12014-12023.
200. Lewis RJ (2011) Discovery and development of the -conopeptide class of analgesic peptides. Toxicon http://dx.doi.org/10.1016/j.toxicon.2011.07.012.
201. Lewis RJ and Garcia ML (2003) Therapeutic potential of venom peptides. Nat Rev Drug Discov 2:790-802.
202. Lewis RJ, Nielsen KJ, Craik DJ, Loughnan ML, Adams DA, Sharpe IA, Luchian T, Adams DJ, Bond T, Thomas L, et al. (2000) Novel ω-conotoxins from Conus catus discriminate among neuronal calcium channel subtypes. J Biol Chem 275:35335-35344.
203. Lewis RJ, Schroeder CI, Ekberg J, Nielsen KJ, Loughnan M, Thomas L, Adams DA, Drinkwater R, Adams DJ, and Alewood PF (2007) Isolation and structure-activity of μ-conotoxin TIIIA, a potent inhibitor of tetrodotoxin-sensitive voltage-gated sodium channels. Mol Pharmacol 71:676-685.
204. + channel pore-blocking toxins and their molecular targets. J Biol Chem 278:30912-30919.
205. + channels revealed by cysteine mutagenesis. Biophys J 73:1874-1884.
206. Li Z, He XP, Xie ZP, Dai QY, and Huang PT (2003b) Effect of new O-superfamily conotoxin SO3 on sodium and potassium currents of cultured hippocampal neurons. Brain Res 965:155-158.
207. Lindia JA and Abbadie C (2003) Distribution of the voltage gated sodium channel Nav1.3-like immunoreactivity in the adult rat central nervous system. Brain Res 960:132-141.
208. Lindia JA, Köhler MG, Martin WJ, and Abbadie C (2005) Relationship between sodium channel Nav1.3 expression and neuropathic pain behavior in rats. Pain 117:145-153.
209. Lipscombe D, Pan JQ, and Gray AC (2002) Functional diversity in neuronal voltagegated calcium channels by alternative splicing of Cavα1. Mol Neurobiol 26:21-44.
210. Liu J, Wu Q, Pi C, Zhao Y, Zhou M, Wang L, Chen S, and Xu A (2007a) Isolation and characterization of a T-superfamily conotoxin from Conus litteratus with targeting tetrodotoxin-sensitive sodium channels. Peptides 28:2313-2319.
211. Liu L, Chew G, Hawrot E, Chi C, and Wang C (2007b) Two potent α3/5 conotoxinsfrom piscivorous Conus achatinus. Acta Biochim Biophys Sin (Shanghai) 39:438-444.
212. Livett BG, Khalil Z, Gayler KR, Down JG, Sandall DW, and Keays DA (2008), inventors; Livett BG, assignee. Alpha conotoxin peptides with analgesic properties. U.S. patent 7,348,400. 2008 Mar 25.
213. Livett BG, Sandall DW, Keays D, Down J, Gayler KR, Satkunanathan N, and Khalil Z (2006) Therapeutic applications of conotoxins that target the neuronal nicotinic acetylcholine receptor. Toxicon 48:810-829.
214. Lluisma AO, López-Vera E, Bulaj G, Watkins M, and Olivera BM (2008) Characterization of a novel ψ-conotoxin from Conus parius Reeve. Toxicon 51:174-180.
215. Loftis JM and Janowsky A (2003) The N-methyl-D-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications. Pharmacol Ther 97:55-85.
216. London C, Hoyt SB, Parsons WH, Williams BS, Warren VA, Tschirret-Guth R, Smith MM, Priest BT, McGowan E, Martin WJ, et al. (2008) Imidazopyridines: a novel class of hNav1.7 channel blockers. Bioorg Med Chem Lett 18:1696-1701.
217. López-Vera E, Aguilar MB, Schiavon E, Marinzi C, Ortiz E, Restano Cassulini R, Batista CV, Possani LD, Heimer de la Cotera EP, Peri F, et al. (2007a) Novel ω-conotoxins from Conus spurius and the α-conotoxin EI share high-affinity potentiation and low-affinity inhibition of nicotinic acetylcholine receptors. FEBS J 274:3972-3985.
218. López-Vera E, Jacobsen RB, Ellison M, Olivera BM, and Teichert RW (2007b) A novel α conotoxin (α-PIB) isolated from C. purpurascens is selective for skeletal muscle nicotinic acetylcholine receptors. Toxicon 49:1193-1199.
219. Loughnan M, Bond T, Atkins A, Cuevas J, Adams DJ, Broxton NM, Livett BG, Down JG, Jones A, Alewood PF, et al. (1998) α-Conotoxin EpI, a novel sulfated peptide from Conus episcopatus that selectively targets neuronal nicotinic acetylcholine receptors. J Biol Chem 273:15667-15674.
220. Loughnan M, Nicke A, Jones A, Schroeder CI, Nevin ST, Adams DJ, Alewood PF, and Lewis RJ (2006) Identification of a novel class of nicotinic receptor antagonists: dimeric conotoxins VxXIIA, VxXIIB, and VxXIIC from Conus vexillum. J Biol Chem 281:24745-24755.
221. Loughnan ML, Nicke A, Jones A, Adams DJ, Alewood PF, and Lewis RJ (2004) Chemical and functional identification and characterization of novel sulfated α-conotoxins from the cone snail Conus anemone. J Med Chem 47:1234-1241.
222. Loughnan ML, Nicke A, Lawrence N, and Lewis RJ (2009) Novel αD-conopeptides and their precursors identified by cDNA cloning define the D-conotoxin superfamily. Biochemistry 48:3717-3729.
223. Lu BS, Yu F, Zhao D, Huang PT, and Huang CF (1999) Conopeptides from Conus striatus and Conus textile by cDNA cloning. Peptides 20:1139-1144.
224. Lubbers NL, Campbell TJ, Polakowski JS, Bulaj G, Layer RT, Moore J, Gross GJ, and Cox BF (2005) Postischemic administration of CGX-1051, a peptide from cone snail venom, reduces infarct size in both rat and dog models of myocardial ischemia and reperfusion. J Cardiovasc Pharmacol 46:141-146.
225. Luo S, Akondi KB, Zhangsun D, Wu Y, Zhu X, Hu Y, Christensen S, Dowell C, Daly NL, Craik DJ, et al. (2010) Atypical alpha-conotoxin LtIA from Conus litteratus targets a novel microsite of the alpha3beta2 nicotinic receptor. J Biol Chem 285:12355-12366.
226. Luo S, Kulak JM, Cartier GE, Jacobsen RB, Yoshikami D, Olivera BM, and McIntosh JM (1998) α-Conotoxin AuIB selectively blocks α3β4 nicotinic acetylcholine receptors and nicotine-evoked norepinephrine release. J Neurosci 18:8571-8579.
227. Luo S, Nguyen TA, Cartier GE, Olivera BM, Yoshikami D, and McIntosh JM (1999) Single-residue alteration in α-conotoxin PnIA switches its nAChR subtype selectivity. Biochemistry 38:14542-14548.
228. Maingret F, Coste B, Padilla F, Clerc N, Crest M, Korogod SM, and Delmas P (2008) Inflammatory mediators increase Nav1.9 current and excitability in nociceptors through a coincident detection mechanism. J Gen Physiol 131:211-225.
229. Malik DK, Baboota S, Ahuja A, Hasan S, and Ali J (2007) Recent advances in protein and peptide drug delivery systems. Curr Drug Deliv 4:141-151.
230. Malmberg AB, Gilbert H, McCabe RT, and Basbaum AI (2003) Powerful antinociceptive effects of the cone snail venom-derived subtype-selective NMDA receptor antagonists conantokins G and T. Pain 101:109-116.
231. Malmberg AB and Yaksh TL (1994) Voltage-sensitive calcium channels in spinal nociceptive processing: blockade of N- and P-type channels inhibits formalininduced nociception. J Neurosci 14:4882-4890.
232. Malmberg AB and Yaksh TL (1995) Effect of continuous intrathecal infusion of ω-conopeptides, N-type calcium-channel blockers, on behavior and antinociception in the formalin and hot-plate tests in rats. Pain 60:83-90.
233. Martinez JS, Olivera BM, Gray WR, Craig AG, Groebe DR, Abramson SN, and McIntosh JM (1995) α-Conotoxin EI, a new nicotinic acetylcholine receptor antagonist with novel selectivity. Biochemistry 34:14519-14526.
234. + channels. Biochem Biophys Res Commun 303:238-246.
235. Matthews EA, Bee LA, Stephens GJ, and Dickenson AH (2007) The Cav2.3 calcium channel antagonist SNX-482 reduces dorsal horn neuronal responses in a rat model of chronic neuropathic pain. Eur J Neurosci 25:3561-3569.
236. Mayer ML and Armstrong N (2004) Structure and function of glutamate receptor ion channels. Annu Rev Physiol 66:161-181.
237. McArthur JR, Singh G, McMaster D, Winkfein R, Tieleman DP, and French RJ (2011) Interactions of key charged residues contributing to selective block of neuronal sodium channels by μ-conotoxin KIIIA. Mol Pharmacol 80:573-584.
238. McCallum SE, Parameswaran N, Bordia T, McIntosh JM, Grady SR, and Quik M (2005) Decrease in α3*/α6* nicotinic receptors but not nicotine-evoked dopamine release in monkey brain after nigrostriatal damage. Mol Pharmacol 68:737-746.
239. McDonough SI, Boland LM, Mintz IM, and Bean BP (2002) Interactions among toxins that inhibit N-type and P-type calcium channels. J Gen Physiol 119:313-328.
240. McGuire D, Bowersox S, Fellmann JD, and Luther RR (1997) Sympatholysis after neuron-specific, N-type, voltage-sensitive calcium channel blockade: first demonstration of N-channel function in humans. J Cardiovasc Pharmacol 30:400-403.
241. McIntosh JM, Absalom N, Chebib M, Elgoyhen AB, and Vincler M (2009) α9 nicotinic acetylcholine receptors and the treatment of pain. Biochem Pharmacol 78:693-702.
242. McIntosh JM, Azam L, Staheli S, Dowell C, Lindstrom JM, Kuryatov A, Garrett JE, Marks MJ, and Whiteaker P (2004) Analogs of α-conotoxin MII are selective for α6-containing nicotinic acetylcholine receptors. Mol Pharmacol 65:944-952.
243. McIntosh JM, Corpuz GO, Layer RT, Garrett JE, Wagstaff JD, Bulaj G, Vyazovkina A, Yoshikami D, Cruz LJ, and Olivera BM (2000) Isolation and characterization of a novel Conus peptide with apparent antinociceptive activity. J Biol Chem 275: 32391-32397.
244. McIntosh JM, Dowell C, Watkins M, Garrett JE, Yoshikami D, and Olivera BM (2002) α-Conotoxin GIC from Conus geographus, a novel peptide antagonist of nicotinic acetylcholine receptors. J Biol Chem 277:33610-33615.
245. McIntosh JM, Hasson A, Spira ME, Gray WR, Li W, Marsh M, Hillyard DR, and Olivera BM (1995) A new family of conotoxins that blocks voltage-gated sodium channels. J Biol Chem 270:16796-16802.
246. McIntosh JM, Olivera BM, Cruz LJ, and Gray WR (1984) γ-Carboxyglutamate in a neuroactive toxin. J Biol Chem 259:14343-14346.
247. McIntosh JM, Plazas PV, Watkins M, Gomez-Casati ME, Olivera BM, and Elgoyhen AB (2005) A novel α-conotoxin, PeIA, cloned from Conus pergrandis, discriminates between rat α9α10 and α7 nicotinic cholinergic receptors. J Biol Chem 280:30107-30112.
248. McIntosh JM, Santos AD, and Olivera BM (1999) Conus peptides targeted to specific nicotinic acetylcholine receptor subtypes. Annu Rev Biochem 68:59-88.
249. McIntosh JM, Yoshikami D, Mahe E, Nielsen DB, Rivier JE, Gray WR, and Olivera BM (1994) A nicotinic acetylcholine receptor ligand of unique specificity, α-conotoxin ImI. J Biol Chem 269:16733-16739.
250. McIntosh M, Cruz LJ, Hunkapiller MW, Gray WR, and Olivera BM (1982) Isolation and structure of a peptide toxin from the marine snail Conus magus. Arch Biochem Biophys 218:329-334.
251. McMaster D, Kobayashi Y, and Lederis K (1992) A vasotocin-like peptide in Aplysia kurodai ganglia: HPLC and RIA evidence for its identity with Lys-conopressin G. Peptides 13:413-421.
252. Messinger RB, Naik AK, Jagodic MM, Nelson MT, Lee WY, Choe WJ, Orestes P, Latham JR, Todorovic SM, and Jevtovic-Todorovic V (2009) In vivo silencing of the Cav3.2 T-type calcium channels in sensory neurons alleviates hyperalgesia in rats with streptozocin-induced diabetic neuropathy. Pain 145:184-195.
253. Miljanich GP (2001) Ziconotide: neuronal calcium channel blocker for treating severe chronic pain. Curr Med Chem 11:3029-3040.
254. Millard EL, Nevin ST, Loughnan ML, Nicke A, Clark RJ, Alewood PF, Lewis RJ, Adams DJ, Craik DJ, and Daly NL (2009) Inhibition of neuronal nicotinic acetylcholine receptor subtypes by α-Conotoxin GID and analogues. J Biol Chem 284: 4944-4951.
255. Milne TJ, Abbenante G, Tyndall JD, Halliday J, and Lewis RJ (2003) Isolation and characterization of a cone snail protease with homology to CRISP proteins of the pathogenesis-related protein superfamily. J Biol Chem 278:31105-31110.
256. Möller C and Marí F (2007) A vasopressin/oxytocin-related conopeptide with γ-carboxyglutamate at position 8. Biochem J 404:413-419.
257. Mondal S, Babu RM, Bhavna R, and Ramakumar S (2007) In silico detection of binding mode of J-superfamily conotoxin pl14a with Kv1.6 channel. In Silico Biol 7:175-186.
258. Monje VD, Haack JA, Naisbitt SR, Miljanich G, Ramachandran J, Nasdasdi L, Olivera BM, Hillyard DR, and Gray WR (1993) A new Conus peptide ligand for Ca channel subtypes. Neuropharmacology 32:1141-1149.
259. Morris JL, Ozols DI, Lewis RJ, Gibbins IL, and Jobling P (2004) Differential involvement of N-type calcium channels in transmitter release from vasoconstrictor and vasodilator neurons. Br J Pharmacol 141:961-970.
260. Motin L and Adams DJ (2008) ω-Conotoxin inhibition of excitatory synaptic transmission evoked by dorsal root stimulation in rat superficial dorsal horn. Neuropharmacology 55:860-864.
261. Motin L, Yasuda T, Schroeder CI, Lewis RJ, and Adams DJ (2007) ω-differentially inhibits native and recombinant N- and P/Q-type calcium channels. Eur J Neurosci 25:435-444.
262. Mouillac B, Chini B, Balestre MN, Jard S, Barberis C, Manning M, Tribollet E, Trumpp-Kallmeyer S, Hoflack J, and Elands J (1995) Identification of agonist binding sites of vasopressin and oxytocin receptors. Adv Exp Med Biol 395:301-310.
263. Mould J, Yasuda T, Schroeder CI, Beedle AM, Doering CJ, Zamponi GW, Adams DJ, and Lewis RJ (2004) The α2δ auxiliary subunit reduces affinity of ω-conotoxins for recombinant N-type (Cav2.2) calcium channels. J Biol Chem 279:34705-34714.
264. Murakami M, Nakagawasai O, Suzuki T, Mobarakeh II, Sakurada Y, Murata A, Yamadera F, Miyoshi I, Yanai K, Tan-No K, et al. (2004) Antinociceptive effect of different types of calcium channel inhibitors and the distribution of various calcium channel α1 subunits in the dorsal horn of spinal cord in mice. Brain Res 1024:122-129.
265. Myers RA, Zafaralla GC, Gray WR, Abbott J, Cruz LJ, and Olivera BM (1991) α-Conotoxins, small peptide probes of nicotinic acetylcholine receptors. Biochemistry 30:9370-9377.
266. Nadasdi L, Yamashiro D, Chung D, Tarczy-Hornoch K, Adriaenssens P, and Ramachandran J (1995) Structure-activity analysis of a Conus peptide blocker of N-type neuronal calcium channels. Biochemistry 34:8076-8081.
267. Nassar MA, Baker MD, Levato A, Ingram R, Mallucci G, McMahon SB, and Wood JN (2006) Nerve injury induces robust allodynia and ectopic discharges in Nav1.3 null mutant mice. Mol Pain 2:33.
268. Nassar MA, Levato A, Stirling LC, and Wood JN (2005) Neuropathic pain develops normally in mice lacking both Nav1.7 and Nav1.8. Mol Pain 1:24.
269. Nassar MA, Stirling LC, Forlani G, Baker MD, Matthews EA, Dickenson AH, and Wood JN (2004) Nociceptor-specific gene deletion reveals a major role for Nav1.7 (PN1) in acute and inflammatory pain. Proc Natl Acad Sci USA 101:12706-12711.
270. Nevin ST, Clark RJ, Klimis H, Christie MJ, Craik DJ, and Adams DJ (2007) Are α9α10 nicotinic acetylcholine receptors a pain target for α-conotoxins? Mol Pharmacol 72:1406-1410.
271. Nicke A, Loughnan ML, Millard EL, Alewood PF, Adams DJ, Daly NL, Craik DJ, and Lewis RJ (2003a) Isolation, structure, and activity of GID, a novel α4/7-conotoxin with an extended N-terminal sequence. J Biol Chem 278:3137-3144.
272. Nicke A, Samochocki M, Loughnan ML, Bansal PS, Maelicke A, and Lewis RJ (2003b) α-Conotoxins EpI and AuIB switch subtype selectivity and activity in native versus recombinant nicotinic acetylcholine receptors. FEBS Lett 554:219-223.
273. Nielsen CK, Lewis RJ, Alewood D, Drinkwater R, Palant E, Patterson M, Yaksh TL, McCumber D, and Smith MT (2005) Anti-allodynic efficacy of the χ-conopeptide, Xen2174, in rats with neuropathic pain. Pain 118:112-124.
274. Nielsen DB, Dykert J, Rivier JE, and McIntosh JM (1994) Isolation of Lysconopressin-G from the venom of the worm-hunting snail, Conus imperialis. Toxicon 32:845-848.
275. Nielsen KJ, Adams D, Thomas L, Bond T, Alewood PF, Craik DJ, and Lewis RJ (1999a) Structure-activity relationships of ω-conotoxins MVIIA, MVIIC and 14 loop splice hybrids at N and P/Q-type calcium channels. J Mol Biol 289:1405-1421.
276. Nielsen KJ, Skjaerbaek N, Dooley M, Adams DA, Mortensen M, Dodd PR, Craik DJ, Alewood PF, and Lewis RJ (1999b) Structure-activity studies of conantokins as human N-methyl-D-aspartate receptor modulators. J Med Chem 42:415-426.
277. Nielsen KJ, Thomas L, Lewis RJ, Alewood PF, and Craik DJ (1996) A consensus structure for ω-conotoxins with different selectivities for voltage-sensitive calcium channel subtypes: comparison of MVIIA, SVIB and SNX-202. J Mol Biol 263:297-310.
278. Niesler B, Frank B, Kapeller J, and Rappold GA (2003) Cloning, physical mapping and expression analysis of the human 5-HT3 serotonin receptor-like genes HTR3C, HTR3D and HTR3E. Gene 310:101-111.
279. Nilsson KP, Lovelace ES, Caesar CE, Tynngård N, Alewood PF, Johansson HM, Sharpe IA, Lewis RJ, Daly NL, and Craik DJ (2005) Solution structure of χ-conopeptide MrIA, a modulator of the human norepinephrine transporter. Biopolymers 80:815-823.
280. + channels and synaptic transmission at the adult, neonatal, and P/Q-type deficient neuromuscular junction. Ann NY Acad Sci 998:11-17.
281. O'Brien BJ, Caldwell JH, Ehring GR, Bumsted O'Brien KM, Luo S, and Levinson SR (2008) Tetrodotoxin-resistant voltage-gated sodium channels Nav1.8 and Nav1.9 are expressed in the retina. J Comp Neurol 508:940-951.
282. Obata H, Conklin D, and Eisenach JC (2005) Spinal noradrenaline transporter inhibition by reboxetine and Xen2174 reduces tactile hypersensitivity after surgery in rats. Pain 113:271-276.
283. Olivera BM, Cruz LJ, de Santos V, LeCheminant GW, Griffin D, Zeikus R, McIntosh JM, Galyean R, Varga J, and Gray WR (1987) Neuronal calcium channel antagonists. Discrimination between calcium channel subtypes using ω-conotoxin from Conus magus venom. Biochemistry 26:2086-2090.
284. Olivera BM, Gray WR, Zeikus R, McIntosh JM, Varga J, Rivier J, de Santos V, and Cruz LJ (1985) Peptide neurotoxins from fish-hunting cone snails. Science 230: 1338-1343.
285. Olivera BM, McIntosh JM, Cruz LJ, Luque FA, and Gray WR (1984) Purification and sequence of a presynaptic peptide toxin from Conus geographus venom. Biochemistry 23:5087-5090.
286. Olivera BM, Miljanich GP, Ramachandran J, and Adams ME (1994) Calcium channel diversity and neurotransmitter release: the ω-conotoxins and ω-agatoxins. Annu Rev Biochem 63:823-867.
287. Olivera BM, Quik M, Vincler M, and McIntosh JM (2008) Subtype-selective conopeptides targeted to nicotinic receptors: Concerted discovery and biomedical applications. Channels (Austin) 2:143-152.
288. + current and enhanced nociceptor excitability require Nav1.9. J Physiol 586:1077-1087.
289. Pande J, Szewczyk MM, and Grover AK (2010) Phage display: concept, innovations, applications and future. Biotechnol Adv 28:849-858.
290. Parsons CG (2001) NMDA receptors as targets for drug action in neuropathic pain. Eur J Pharmacol 429:71-78.
291. Payandeh J, Scheuer T, Zheng N, and Catterall WA (2011) The crystal structure of a voltage-gated sodium channel. Nature 475:353-358.
292. Peng C, Chen W, Han Y, Sanders T, Chew G, Liu J, Hawrot E, Chi C, and Wang C (2009) Characterization of a novel α4/4-conotoxin, Qc1.2, from vermivorous Conus quercinus. Acta Biochim Biophys Sin (Shanghai) 41:858-864.
293. Peng C, Liu L, Shao X, Chi C, and Wang C (2008) Identification of a novel class of conotoxins defined as V-conotoxins with a unique cysteine pattern and signal peptide sequence. Peptides 29:985-991.
294. Peng C, Tang S, Pi C, Liu J, Wang F, Wang L, Zhou W, and Xu A (2006) Discovery of a novel class of conotoxin from Conus litteratus, lt14a, with a unique cysteine pattern. Peptides 27:2174-2181.
295. Penn RD and Paice JA (2000) Adverse effects associated with the intrathecal administration of ziconotide. Pain 85:291-296.
296. Perry DC, Mao D, Gold AB, McIntosh JM, Pezzullo JC, and Kellar KJ (2007) Chronic nicotine differentially regulates α6- and β3-containing nicotinic cholinergic receptors in rat brain. J Pharmacol Exp Ther 322:306-315.
297. Pertin M, Ji RR, Berta T, Powell AJ, Karchewski L, Tate SN, Isom LL, Woolf CJ, Gilliard N, Spahn DR, et al. (2005) Upregulation of the voltage-gated sodium channel 2 subunit in neuropathic pain models: characterization of expression in injured and non-injured primary sensory neurons. J Neurosci 25:10970-10980.
298. Petersson M (2002) Cardiovascular effects of oxytocin. Prog Brain Res 139:281-288.
299. Pi C, Liu J, Wang L, Jiang X, Liu Y, Peng C, Chen S, and Xu A (2007) Soluble expression, purification and functional identification of a disulfide-rich conotoxin derived from Conus litteratus. J Biotechnol 128:184-193.
300. Postina R, Kojro E, and Fahrenholz F (1996) Separate agonist and peptide antagonist binding sites of the oxytocin receptor defined by their transfer into the V2 vasopressin receptor. J Biol Chem 271:31593-31601.
301. Priest BT, Murphy BA, Lindia JA, Diaz C, Abbadie C, Ritter AM, Liberator P, Iyer LM, Kash SF, Kohler MG, et al. (2005) Contribution of the tetrodotoxin-resistant voltage-gated sodium channel Nav1.9 to sensory transmission and nociceptive behavior. Proc Natl Acad Sci USA 102:9382-9387.
302. Quik M, Bordia T, Forno L, and McIntosh JM (2004) Loss of α-conotoxinMII- and A85380-sensitive nicotinic receptors in Parkinson's disease striatum. J Neurochem 88:668-679.
303. Quiram PA, Jones JJ, and Sine SM (1999) Pairwise interactions between neuronal α7 acetylcholine receptors and α-conotoxin ImI. J Biol Chem 274:19517-19524.
304. Quiram PA and Sine SM (1998a) Identification of residues in the neuronal α7 acetylcholine receptor that confer selectivity for conotoxin ImI. J Biol Chem 273:11001-11006.
305. Quiram PA and Sine SM (1998b) Structural elements in α-conotoxin ImI essential for binding to neuronal α7 receptors. J Biol Chem 273:11007-11011.
306. Raingo J, Castiglioni AJ, and Lipscombe D (2007) Alternative splicing controls G protein-dependent inhibition of N-type calcium channels in nociceptors. Nat Neurosci 10:285-292.
307. Ramilo CA, Zafaralla GC, Nadasdi L, Hammerland LG, Yoshikami D, Gray WR, Kristipati R, Ramachandran J, Miljanich G, and Olivera BM (1992) Novel α- and ω-conotoxins from Conus striatus venom. Biochemistry 31:9919-9926.
308. Rashid MH and Ueda H (2002) Neuropathy-specific analgesic action of intrathecal nicotinic agonists and its spinal GABA-mediated mechanism. Brain Res 953: 53-62.
309. Rasmussen SG, Choi HJ, Fung JJ, Pardon E, Casarosa P, Chae PS, Devree BT, Rosenbaum DM, Thian FS, Kobilka TS, et al. (2011a) Structure of a nanobodystabilized active state of the 2 adrenoceptor. Nature 469:175-180.
310. Rasmussen SG, Choi HJ, Rosenbaum DM, Kobilka TS, Thian FS, Edwards PC, Burghammer M, Ratnala VR, Sanishvili R, Fischetti RF, et al. (2007) Crystal structure of the human 2 adrenergic G-protein-coupled receptor. Nature 450: 383-387.
311. Rasmussen SG, DeVree BT, Zou Y, Kruse AC, Chung KY, Kobilka TS, Thian FS, Chae PS, Pardon E, Calinski D, et al. (2011b) Crystal structure of the 2 adrenergic receptor-Gs protein complex. Nature 477:549-555.
312. Rau KK, Johnson RD, and Cooper BY (2005) Nicotinic AChR in subclassified capsaicin-sensitive and -insensitive nociceptors of the rat DRG. J Neurophysiol 93: 1358-1371.
313. Raymond CK, Castle J, Garrett-Engele P, Armour CD, Kan Z, Tsinoremas N, and Johnson JM (2004) Expression of alternatively spliced sodium channel α-subunit genes. Unique splicing patterns are observed in dorsal root ganglia. J Biol Chem 279:46234-46241.
314. Reimann F, Cox JJ, Belfer I, Diatchenko L, Zaykin DV, McHale DP, Drenth JP, Dai F, Wheeler J, Sanders F, et al. (2010) Pain perception is altered by a nucleotide polymorphism in SCN9A. Proc Natl Acad Sci USA 107:5148-5153.
315. Rodrigo J, Pena A, Murat B, Trueba M, Durroux T, Guillon G, and Rognan D (2007) Mapping the binding site of arginine vasopressin to V1a and V1b vasopressin receptors. Mol Endocrinol 21:512-523.
316. Rosenbaum DM, Zhang C, Lyons JA, Holl R, Aragao D, Arlow DH, Rasmussen SG, Choi HJ, Devree BT, Sunahara RK, et al. (2011) Structure and function of an irreversible agonist-2 adrenoceptor complex. Nature 469:236-240.
317. + channel Nav1.8 is essential for the expression of spontaneous activity in damaged sensory axons of mice. J Physiol 550:921-926.
318. + current and Nav1.9 subunit in myenteric sensory neurons. J Neurosci 23:2715-2725.
319. Rycroft BK, Vikman KS, and Christie MJ (2007) Inflammation reduces the contribution of N-type calcium channels to primary afferent synaptic transmission onto NK1 receptor-positive lamina I neurons in the rat dorsal horn. J Physiol 580:883-894.
320. Safo P, Rosenbaum T, Shcherbatko A, Choi DY, Han E, Toledo-Aral JJ, Olivera BM, Brehm P, and Mandel G (2000) Distinction among neuronal subtypes of voltageactivated sodium channels by μ-conotoxin PIIIA. J Neurosci 20:76-80.
321. Sala F, Nistri A, and Criado M (2008) Nicotinic acetylcholine receptors of adrenal chromaffin cells. Acta Physiol (Oxf) 192:203-212.
322. Salzet M, Bulet P, Van Dorsselaer A, and Malecha J (1993) Isolation, structural characterization and biological function of a lysine-conopressin in the central nervous system of the pharyngobdellid leech Erpobdella octoculata. Eur J Biochem 217:897-903.
323. Sandall DW, Satkunanathan N, Keays DA, Polidano MA, Liping X, Pham V, Down JG, Khalil Z, Livett BG, and Gayler KR (2003) A novel α-conotoxin identified by gene sequencing is active in suppressing the vascular response to selective stimulation of sensory nerves in vivo. Biochemistry 42:6904-6911.
324. Santos AD, McIntosh JM, Hillyard DR, Cruz LJ, and Olivera BM (2004) The A-superfamily of conotoxins: structural and functional divergence. J Biol Chem 279:17596-17606.
325. Sarma SP, Kumar GS, Sudarslal S, Iengar P, Ramasamy P, Sikdar SK, Krishnan KS, and Balaram P (2005) Solution structure of δ-Am2766: a highly hydrophobic δ-conotoxin from Conus amadis that inhibits inactivation of neuronal voltagegated sodium channels. Chem Biodivers 2:535-556.
326. Sasaki T, Feng ZP, Scott R, Grigoriev N, Syed NI, Fainzilber M, and Sato K (1999) Synthesis, bioactivity, and cloning of the L-type calcium channel blocker ω-conotoxin TxVII. Biochemistry 38:12876-12884.
327. Satkunanathan N, Livett B, Gayler K, Sandall D, Down J, and Khalil Z (2005) α-Conotoxin Vc1.1 alleviates neuropathic pain and accelerates functional recovery of injured neurones. Brain Res 1059:149-158.
328. Sato K, Ishida Y, Wakamatsu K, Kato R, Honda H, Ohizumi Y, Nakamura H, Ohya M, Lancelin JM, and Kohda D (1991) Active site of μ-conotoxin GIIIA, a peptide blocker of muscle sodium channels. J Biol Chem 266:16989-16991.
329. Sato K, Park NG, Kohno T, Maeda T, Kim JI, Kato R, and Takahashi M (1993) Role of basic residues for the binding of ω-conotoxin GVIA to N-type calcium channels. Biochem Biophys Res Commun 194:1292-1296.
330. Savarin P, Guenneugues M, Gilquin B, Lamthanh H, Gasparini S, Zinn-Justin S, and Ménez A (1998) Three-dimensional structure of κ-conotoxin PVIIA, a novel potassium channel-blocking toxin from cone snails. Biochemistry 37:5407-5416.
331. Scanio MJ, Shi L, Drizin I, Gregg RJ, Atkinson RN, Thomas JB, Johnson MS, Chapman ML, Liu D, Krambis MJ, et al. (2010) Discovery and biological evaluation of potent, selective, orally bioavailable, pyrazine-based blockers of the Nav1.8 sodium channel with efficacy in a model of neuropathic pain. Bioorg Med Chem 18:7816-7825.
332. Scanlon MJ, Naranjo D, Thomas L, Alewood PF, Lewis RJ, and Craik DJ (1997) Solution structure and proposed binding mechanism of a novel potassium channel toxin κ-conotoxin PVIIA. Structure 5:1585-1597.
333. Schmalhofer WA, Calhoun J, Burrows R, Bailey T, Kohler MG, Weinglass AB, Kaczorowski GJ, Garcia ML, Koltzenburg M, and Priest BT (2008) ProTx-II, a selective inhibitor of Nav1.7 sodium channels, blocks action potential propagation in nociceptors. Mol Pharmacol 74:1476-1484.
334. Schmidtko A, Lötsch J, Freynhagen R, and Geisslinger G (2010) Ziconotide for treatment of severe chronic pain. Lancet 375:1569-1577.
335. Schroeder CI, Ekberg J, Nielsen KJ, Adams D, Loughnan ML, Thomas L, Adams DJ, Alewood PF, and Lewis RJ (2008) Neuronally μ-conotoxins from Conus striatus utilize an α-helical motif to target mammalian sodium channels. J Biol Chem 283:21621-21628.
336. Schroeder CI, Smythe ML, and Lewis RJ (2004) Development of small molecules that mimic the binding of ω-conotoxins at the N-type voltage-gated calcium channel. Mol Divers 8:127-134.
337. Scott DA, Wright CE, and Angus JA (2002) Actions of intrathecal ω-conotoxins CVID, GVIA, MVIIA, and morphine in acute and neuropathic pain in the rat. Eur J Pharmacol 451:279-286.
338. Shah BS, Stevens EB, Gonzalez MI, Bramwell S, Pinnock RD, Lee K, and Dixon AK (2000) 3, a novel auxiliary subunit for the voltage-gated sodium channel, is expressed preferentially in sensory neurons and is upregulated in the chronic constriction injury model of neuropathic pain. Eur J Neurosci 12:3985-3990.
339. Sharpe IA, Gehrmann J, Loughnan ML, Thomas L, Adams DA, Atkins A, Palant E, Craik DJ, Adams DJ, Alewood PF, et al. (2001) Two new classes of conopeptides inhibit the α1-adrenoceptor and noradrenaline transporter. Nat Neurosci 4:902-907.
340. + dependence, and structure-activity relationship. J Biol Chem 278:40317-40323.
341. Sharpe IA, Thomas L, Loughnan M, Motin L, Palant E, Croker DE, Alewood D, Chen S, Graham RM, Alewood PF, et al. (2003b) Allosteric α1-adrenoreceptor antagonism by the conopeptide ρ-TIA. J Biol Chem 278:34451-34457.
342. Shichor I, Fainzilber M, Pelhate M, Malecot CO, Zlotkin E, and Gordon D (1996) Interactions of δ-conotoxins with alkaloid neurotoxins reveal differences between the silent and effective binding sites on voltage-sensitive sodium channels. J Neurochem 67:2451-2460.
343. Shon KJ, Grilley M, Jacobsen R, Cartier GE, Hopkins C, Gray WR, Watkins M, Hillyard DR, Rivier J, Torres J, et al. (1997) A noncompetitive peptide inhibitor of the nicotinic acetylcholine receptor from Conus purpurascens venom. Biochemistry 36:9581-9587.
344. Shon KJ, Hasson A, Spira ME, Cruz LJ, Gray WR, and Olivera BM (1994) δ-Conotoxin GmVIA, a novel peptide from the venom of Conus gloriamaris. Biochemistry 33:11420-11425.
345. Shon KJ, Olivera BM, Watkins M, Jacobsen RB, Gray WR, Floresca CZ, Cruz LJ, Hillyard DR, Brink A, Terlau H, et al. (1998a) μ-Conotoxin PIIIA, a new peptide for discriminating among tetrodotoxin-sensitive Na channel subtypes. J Neurosci 18:4473-4481.
346. + channel. J Biol Chem 273:33-38.
347. Smith MT, Cabot PJ, Ross FB, Robertson AD, and Lewis RJ (2002) The novel N-type calcium channel blocker, AM336, produces potent dose-dependent antinociception after intrathecal dosing in rats and inhibits substance P release in rat spinal cord slices. Pain 96:119-127.
348. Sobolevsky AI, Rosconi MP, and Gouaux E (2009) X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor. Nature 462:745-756.
349. + channels. J Neurosci 17:3002-3013.
350. Sudarslal S, Majumdar S, Ramasamy P, Dhawan R, Pal PP, Ramaswami M, Lala AK, Sikdar SK, Sarma SP, Krishnan KS, et al. (2003) Sodium channel modulating activity in a δ-conotoxin from an Indian marine snail. FEBS Lett 553:209-212.
351. Sun D, Ren Z, Zeng X, You Y, Pan W, Zhou M, Wang L, and Xu A (2011) Structurefunction relationship of conotoxin lt14a, a potential analgesic with low cytotoxicity. Peptides 32:300-305.
352. Takasusuki T and Yaksh TL (2011) The effects of intrathecal and systemic gabapentin on spinal substance P release. Anesth Analg 112:971-976.
353. Talley TT, Olivera BM, Han KH, Christensen SB, Dowell C, Tsigelny I, Ho KY, Taylor P, and McIntosh JM (2006) α-Conotoxin OmIA is a potent ligand for the acetylcholine-binding protein as well as α3β2 and α7 nicotinic acetylcholine receptors. J Biol Chem 281:24678-24686.
354. Tanaka K, Masu M, and Nakanishi S (1990) Structure and functional expression of the cloned rat neurotensin receptor. Neuron 4:847-854.
355. Teichert RW, Jacobsen R, Terlau H, Yoshikami D, and Olivera BM (2007a) Discovery and characterization of the short κA-conotoxins: a novel subfamily of excitatory conotoxins. Toxicon 49:318-328.
356. Teichert RW, Jimenez EC, and Olivera BM (2005a) αS-conotoxin RVIIIA: a structurally unique conotoxin that broadly targets nicotinic acetylcholine receptors. Biochemistry 44:7897-7902.
357. Teichert RW, Jimenez EC, Twede V, Watkins M, Hollmann M, Bulaj G, and Olivera BM (2007b) Novel conantokins from Conus parius venom are specific antagonists of N-methyl-D-aspartate receptors. J Biol Chem 282:36905-36913.
358. Teichert RW, López-Vera E, Gulyas J, Watkins M, Rivier J, and Olivera BM (2006) Definition and characterization of the short αA-conotoxins: a single residue determines dissociation kinetics from the fetal muscle nicotinic acetylcholine receptor. Biochemistry 45:1304-1312.
359. Teichert RW, Rivier J, Dykert J, Cervini L, Gulyas J, Bulaj G, Ellison M, and Olivera BM (2004) αA-Conotoxin OIVA defines a new αA-conotoxin subfamily of nicotinic acetylcholine receptor inhibitors. Toxicon 44:207-214.
360. Teichert RW, Rivier J, Torres J, Dykert J, Miller C, and Olivera BM (2005b) A uniquely selective inhibitor of the mammalian fetal neuromuscular nicotinic acetylcholine receptor. J Neurosci 25:732-736.
361. Terlau H and Olivera BM (2004) Conus venoms: a rich source of novel ion channeltargeted peptides. Physiol Rev 84:41-68.
362. Terlau H, Shon KJ, Grilley M, Stocker M, Stühmer W, and Olivera BM (1996) Strategy for rapid immobilization of prey by a fish-hunting marine snail. Nature 381:148-151.
363. Thakor DK, Lin A, Matsuka Y, Meyer EM, Ruangsri S, Nishimura I, and Spigelman I (2009) Increased peripheral nerve excitability and local Nav1.8 mRNA upregulation in painful neuropathy. Mol Pain 5:14.
364. Todorovic SM and Jevtovic-Todorovic V (2011) T-type voltage-gated calcium channels as targets for the development of novel pain therapies. Br J Pharmacol 163:484-495.
365. Triggle DJ (2007) Calcium channel antagonists: clinical uses-past, present and future. Biochem Pharmacol 74:1-9.
366. Twede VD, Teichert RW, Walker CS, Gruszczyński P, Kaźmierkiewicz R, Bulaj G, and Olivera BM (2009) Conantokin-Br from Conus brettinghami and selectivity determinants for the NR2D subunit of the NMDA receptor. Biochemistry 48:4063-4073.
367. Uchitel OD, Protti DA, Sanchez V, Cherksey BD, Sugimori M, and Llinás R (1992) P-type voltage-dependent calcium channel mediates presynaptic calcium influx and transmitter release in mammalian synapses. Proc Natl Acad Sci USA 89: 3330-3333.
368. Ueberheide BM, Fenyö D, Alewood PF, and Chait BT (2009) Rapid sensitive analysis of cysteine rich peptide venom components. Proc Natl Acad Sci USA 106:6910-6915.
369. Ulens C, Hogg RC, Celie PH, Bertrand D, Tsetlin V, Smit AB, and Sixma TK (2006) Structural determinants of selective α-conotoxin binding to a nicotinic acetylcholine receptor homolog AChBP. Proc Natl Acad Sci USA 103:3615-3620.
370. Van Der Haegen A, Peigneur S, and Tytgat J (2011) Importance of position 8 in μ-conotoxin KIIIA for voltage-gated sodium channel selectivity. FEBS J 278: 3408-3418
371. Van Kesteren RE, Smit AB, De Lange RP, Kits KS, Van Golen FA, Van Der Schors RC, De With ND, Burke JF, and Geraerts WP (1995) Structural and functional evolution of the vasopressin/oxytocin superfamily: vasopressin-related conopressin is the only member present in Lymnaea, and is involved in the control of sexual behavior. J Neurosci 15:5989-5998.
372. Van Wagoner RM, Jacobsen RB, Olivera BM, and Ireland CM (2003) Characterization and three-dimensional structure determination of ψ-conotoxin PIIIf, a novel noncompetitive antagonist of nicotinic acetylcholine receptors. Biochemistry 42: 6353-6362.
373. Vanegas H and Schaible H (2000) Effects of antagonists to high-threshold calcium channels upon spinal mechanisms of pain, hyperalgesia and allodynia. Pain 85: 9-18.
374. + channels. J Biol Chem 280:21246-21255.
375. Vetter DE, Katz E, Maison SF, Taranda J, Turcan S, Ballestero J, Liberman MC, Elgoyhen AB, and Boulter J (2007) The α10 nicotinic acetylcholine receptor subunit is required for normal synaptic function and integrity of the olivocochlear system. Proc Natl Acad Sci USA 104:20594-20599.
376. Vincler M and McIntosh JM (2007) Targeting the α9α10 nicotinic acetylcholine receptor to treat severe pain. Expert Opin Ther Targets 11:891-897.
377. Vincler M, Wittenauer S, Parker R, Ellison M, Olivera BM, and McIntosh JM (2006) Molecular mechanism for analgesia involving specific antagonism of α9α10 nicotinic acetylcholine receptors. Proc Natl Acad Sci USA 103:17880-17884.
378. Vita N, Laurent P, Lefort S, Chalon P, Dumont X, Kaghad M, Gully D, Le Fur G, Ferrara P, and Caput D (1993) Cloning and expression of a complementary DNA encoding a high affinity human neurotensin receptor. FEBS Lett 317:139-142.
379. Vita N, Oury-Donat F, Chalon P, Guillemot M, Kaghad M, Bachy A, Thurneyssen O, Garcia S, Poinot-Chazel C, Casellas P, et al. (1998) Neurotensin is an antagonist of the human neurotensin NT2 receptor expressed in Chinese hamster ovary cells. Eur J Pharmacol 360:265-272.
380. Walewska A, Skalicky JJ, Davis DR, Zhang MM, Lopez-Vera E, Watkins M, Han TS, Yoshikami D, Olivera BM, and Bulaj G (2008) NMR-based mapping of disulfide bridges in cysteine-rich peptides: application to the μ-conotoxin SxIIIA. J Am Chem Soc 130:14280-14286.
381. Walker CS, Jensen S, Ellison M, Matta JA, Lee WY, Imperial JS, Duclos N, Brockie PJ, Madsen DM, Isaac JT, et al. (2009) A novel Conus snail polypeptide causes excitotoxicity by blocking desensitization of AMPA receptors. Curr Biol 19:900-908.
382. Wang L, Liu J, Pi C, Zeng X, Zhou M, Jiang X, Chen S, Ren Z, and Xu A (2009) Identification of a novel M-superfamily conotoxin with the ability to enhance tetrodotoxin sensitive sodium currents. Arch Toxicol 83:925-932.
383. Wang L, Pi C, Liu J, Chen S, Peng C, Sun D, Zhou M, Xiang H, Ren Z, and Xu A (2008) Identification and characterization of a novel O-superfamily conotoxin from Conus litteratus. J Pept Sci 14:1077-1083.
384. Wang YX, Bezprozvannaya S, Bowersox SS, Nadasdi L, Miljanich G, Mezo G, Silva D, Tarczy-Hornoch K, and Luther RR (1998) Peripheral versus central potencies of N-type voltage-sensitive calcium channel blockers. Naunyn Schmiedebergs Arch Pharmacol 357:159-168.
385. Warne T, Moukhametzianov R, Baker JG, Nehmé R, Edwards PC, Leslie AG, Schertler GF, and Tate CG (2011) The structural basis for agonist and partial agonist action on a 1-adrenergic receptor. Nature 469:241-244.
386. Warne T, Serrano-Vega MJ, Baker JG, Moukhametzianov R, Edwards PC, Henderson R, Leslie AG, Tate CG, and Schertler GF (2008) Structure of a 1-adrenergic G-protein-coupled receptor. Nature 454:486-491.
387. Weiss J, Pyrski M, Jacobi E, Bufe B, Willnecker V, Schick B, Zizzari P, Gossage SJ, Greer CA, Leinders-Zufall T, et al. (2011) Loss-of-function mutations in sodium channel Nav1.7 cause anosmia. Nature 472:186-190.
388. Wen L, Yang S, Qiao H, Liu Z, Zhou W, Zhang Y, and Huang P (2005) SO-3, a new O-superfamily conopeptide derived from Conus striatus, selectively inhibits N-type calcium currents in cultured hippocampal neurons. Br J Pharmacol 145:728-739.
389. Wermeling D, Drass M, Ellis D, Mayo M, McGuire D, O'Connell D, Hale V, and Chao S (2003) Pharmacokinetics and pharmacodynamics of intrathecal Ziconotide in chronic pain patients. J Clin Pharmacol 43:624-636.
390. West PJ, Bulaj G, Garrett JE, Olivera BM, and Yoshikami D (2002) μ-Conotoxin SmIIIA, a potent inhibitor of tetrodotoxin-resistant sodium channels in amphibian sympathetic and sensory neurons. Biochemistry 41:15388-15393.
391. + channel subtypes on rat spinal motor neurons, interneurons, and nerve terminals. J Neurosci 18:6319-6330.
392. White HS, McCabe RT, Armstrong H, Donevan SD, Cruz LJ, Abogadie FC, Torres J, Rivier JE, Paarmann I, Hollmann M, et al. (2000) In vitro and in vivo characterization of conantokin-R, a selective NMDA receptor antagonist isolated from the venom of the fish-hunting snail Conus radiatus. J Pharmacol Exp Ther 292:425-432.
393. Whiteaker P, Christensen S, Yoshikami D, Dowell C, Watkins M, Gulyas J, Rivier J, Olivera BM, and McIntosh JM (2007) Discovery, synthesis, and structure activity of a highly selective α7 nicotinic acetylcholine receptor antagonist. Biochemistry 46:6628-6638.
394. Whiteaker P, Marks MJ, Christensen S, Dowell C, Collins AC, and McIntosh JM (2008) Synthesis and characterization of 125I-α-conotoxin ArIB[V11L;V16A], a selective α7 nicotinic acetylcholine receptor antagonist. J Pharmacol Exp Ther 325:910-919.
395. Williams BS, Felix JP, Priest BT, Brochu RM, Dai K, Hoyt SB, London C, Tang YS, Duffy JL, Parsons WH, et al. (2007) Characterization of a new class of potent inhibitors of the voltage-gated sodium channel Nav1.7. Biochemistry 46:14693-14703.
396. Wilson MJ, Yoshikami D, Azam L, Gajewiak J, Olivera BM, Bulaj G, and Zhang MM (2011a) μ-Conotoxins that differentially block sodium channels Nav1.1 through 1.8 identify those responsible for action potentials in sciatic nerve. Proc Natl Acad Sci USA 108:10302-10307.
397. Wilson MJ, Zhang MM, Azam L, Olivera BM, Bulaj G, and Yoshikami D (2011b) Navβ subunits modulate the inhibition of Nav1.8 by the analgesic gating modifier μO-conotoxin MrVIB. J Pharmacol Exp Ther 338:687-693.
398. Winquist RJ, Pan JQ, and Gribkoff VK (2005) Use-dependent blockade of Cav2.2 voltage-gated calcium channels for neuropathic pain. Biochem Pharmacol 70:489-499.
399. Wittekindt B, Malany S, Schemm R, Otvos L, Maccecchini ML, Laube B, and Betz H (2001) Point mutations identify the glutamate binding pocket of the N-methyl-daspartate receptor as major site of conantokin-G inhibition. Neuropharmacology 41:753-761.
400. Woppmann A, Ramachandran J, and Miljanich GP (1994) Calcium channel subtypes in rat brain: biochemical characterization of the high-affinity receptors for ω-conopeptides SNX-230 (synthetic MVIIC), SNX-183 (SVIB), and SNX-111 (MVIIA). Mol Cell Neurosci 5:350-357.
401. + channel blockade is amplified in experimental hypertension. J Hypertens 18:65-73.
402. Xiao Y, Bingham JP, Zhu W, Moczydlowski E, Liang S, and Cummins TR (2008a) Tarantula huwentoxin-IV inhibits neuronal sodium channels by binding to receptor site 4 and trapping the domain ii voltage sensor in the closed configuration. J Biol Chem 283:27300-27313.
403. Xiao Y, Luo X, Kuang F, Deng M, Wang M, Zeng X, and Liang S (2008b) Synthesis and characterization of huwentoxin-IV, a neurotoxin inhibiting central neuronal sodium channels. Toxicon 51:230-239.
404. Yaksh TL (2006) Calcium channels as therapeutic targets in neuropathic pain. J Pain 7:S13-30.
405. Yanagawa Y, Abe T, Satake M, Odani S, Suzuki J, and Ishikawa K (1988) A novel sodium channel inhibitor from Conus geographus: purification, structure, and pharmacological properties. Biochemistry 27:6256-6262.
406. Yao S, Zhang MM, Yoshikami D, Azam L, Olivera BM, Bulaj G, and Norton RS (2008) Structure, dynamics, and selectivity of the sodium channel blocker μ-conotoxin SIIIA. Biochemistry 47:10940-10949.
407. Zafaralla GC, Ramilo C, Gray WR, Karlstrom R, Olivera BM, and Cruz LJ (1988) Phylogenetic specificity of cholinergic ligands: α-conotoxin SI. Biochemistry 27: 7102-7105.
408. Zamponi GW, Lewis RJ, Todorovic SM, Arneric SP, and Snutch TP (2009) Role of voltage-gated calcium channels in ascending pain pathways. Brain Res Rev 60: 84-89.
409. Zhang H, Fu Y, Altier C, Platzer J, Surmeier DJ, and Bezprozvanny I (2006a) Cav1.2 and Cav1.3 neuronal L-type calcium channels: differential targeting and signaling to pCREB. Eur J Neurosci 23:2297-2310.
410. Zhang MM, Fiedler B, Green BR, Catlin P, Watkins M, Garrett JE, Smith BJ, Yoshikami D, Olivera BM, and Bulaj G (2006b) Structural and functional diversities among μ-conotoxins targeting TTX-resistant sodium channels. Biochemistry 45:3723-3732.
411. Zhang MM, Green BR, Catlin P, Fiedler B, Azam L, Chadwick A, Terlau H, McArthur JR, French RJ, Gulyas J, et al. (2007) Structure/function characterization of μ-conotoxin KIIIA, an analgesic, nearly irreversible blocker of mammalian neuronal sodium channels. J Biol Chem 282:30699-30706.
412. Zhang MM, Han TS, Olivera BM, Bulaj G, and Yoshikami D (2010) μ-Conotoxin KIIIA derivatives with divergent affinities versus efficacies in blocking voltagegated sodium channels. Biochemistry 49:4804-4812.
413. Zhao D and Huang P (2000) Cloning of novel conotoxin precursor sequences from Conus pulicarius. Prog Nat Sci 10:33-36.
414. Zheng G, Zhang Z, Dowell C, Wala E, Dwoskin LP, Holtman JR, McIntosh JM, and Crooks PA (2011) Discovery of non-peptide, small molecule antagonists of α9α10 nicotinic acetylcholine receptors as novel analgesics for the treatment of neuropathic and tonic inflammatory pain. Bioorg Med Chem Lett 21:2476-2479.
415. Zhu S, Gao B, Deng M, Yuan Y, Luo L, Peigneur S, Xiao Y, Liang S, and Tytgat J (2010) Drosotoxin, a selective inhibitor of tetrodotoxin-resistant sodium channels. Biochem Pharmacol 80:1296-1302.
416. Zorn S, Leipold E, Hansel A, Bulaj G, Olivera BM, Terlau H, and Heinemann SH (2006) The μO-conotoxin MrVIA inhibits voltage-gated sodium channels by associating with domain-3. FEBS Lett 580:1360-1364.